白细胞介素-1β与皮质醇诱导人胎儿肺与羊膜成纤维细胞11β-HSD1表达的分子机制
|
摘要
胎儿器官成熟特别是肺成熟与分娩发动是一个协同进行的过程,而这一过程依赖于妊娠晚期内源性糖皮质激素的增加。由于人类胎儿肾上腺的特殊结构和胎盘糖皮质激素屏障的存在,妊娠晚期胎儿组织11β-羟基类固醇脱氢酶Ⅰ型(11β-Hydroxysteroid dehydrogenase type 1,11β-HSD1)对17-羟-11-脱氢皮质酮的活化作用可能成为胎儿体内糖皮质激素的重要来源。目前已有充分证据表明,大多数动物胎儿肺能够表达11β-HSD1,而且11β-HSD1-/-小鼠肺成熟出现障碍,提不11β-HSD1在胎儿肺成熟中的关键作用,但人胎儿组织特别是肺是否表达11β-HSD1目前还不明了。以往研究发现,人胎膜表达的11β-HSD1也为胎儿器官成熟提供重要的糖皮质激素来源,糖皮质激素和促炎性细胞因子作为抑炎和促炎的两种因子却都可以诱导胎膜11β-HSD1的表达,但其分子机制目前尚未阐明。本课题采用免疫组织化学、常规PCR、Western blotting、实时荧光定量PCR、酶活性测定、启动子克隆与活性测定、功能蛋白过表达、染色质免疫沉淀(ChIP)和凝胶电泳迁移实验(EMSA)等技术,首先研究了人胎儿肺组织是否表达11β-HSD1,然后分别以人胎儿肺成纤维细胞株(HFL-1)和原代培养人羊膜成纤维细胞为研究模型,研究了促炎性细胞因子(白细胞介素-1β)和糖皮质激素(皮质醇)诱导11β-HSD1表达的分子机制。
1.常规PCR和免疫组织化学染色结果表明,妊娠中期(孕4个月)和晚期(孕8个月)人胎肺组织中都能够检测到11β-HSD1 mRNA,但只在妊娠晚期胎肺组织中检测到11β-HSD1的分布,包括小支气管和细支气管的上皮细胞和小支气管间质细胞。此外,在HFL-1细胞中也检测到了11β-HSD1mRNA和蛋白,而且用Western blotting和酶活性测定的方法证实了上述结果。此结果不但提示胎儿肺组织至少在妊娠晚期可以表达11β-HSD1蛋白,而且也提示HFL-1细胞是进一步研究胎儿肺11β-HSD1表达调控的良好实验模型。
2.以HFL-1细胞和原代培养的人羊膜成纤维细胞为研究模型,用实时荧光定量PCR、Western blotting和酶活性测定等方法研究发现,白细胞介素-1β与皮质醇增加11β-HSD1 mRNA和蛋白水平的现象同时存在于HFL-1细胞和原代培养的人羊膜成纤维细胞中。
3.实时荧光定量PCR测定结果表明,白细胞介素-1β与皮质醇对人羊膜成纤维细胞和HFL-1细胞11β-HSD1 mRNA表达的诱导作用能够被mRNA转录抑制剂DRB和蛋白质合成抑制剂CHX阻断,提示白细胞介素-1β与皮质醇增加11β-HSD1mRNA水平的作用发生在转录水平并需要蛋白质合成的参与。用表达拮抗C/EBP蛋白的质粒(CMV-500-A-C/EBP)转染HFL-1细胞和人羊膜成纤维细胞发现,白细胞介素-1β与皮质醇诱导11β-HSD1 mRNA表达作用均可以被不同程度阻断,提示在上述两种细胞中C/EBPs家族成员均参与了白细胞介素-1β与皮质醇诱导11β-HSD1 mRNA表达作用。
4.我们以HFL-1细胞为模型进一步研究了白细胞介素-1β诱导11β-HSD1 mRNA表达的分子机制。结果表明：(1)NF-kB转录激活抑制剂5HPP-33不能阻断白细胞介素-1β对HFL-1细胞11β-HSD1 mRNA表达的诱导作用,但能够阻断白细胞介素-1β对炎症介质前列腺素合成酶COX-2 mRNA的诱导作用,提示白细胞介素-1β对11β-HSD1 mRNA表达的促进作用与此经典的炎症通路无关。(2)将11β-HSD1启动子克隆并构建于报告基因质粒,转染HFL-1细胞后测定其启动子活性发现,白细胞介素-1β能够促进11β-HSD1启动子活性增加,此作用可以被CCAAT序列突变所阻断。(3)Western blotting分析结果表明,HFL-1细胞中主要表达C/EBPβ而几乎不表达C/EBPα,白细胞介素-1β强烈诱导C/EBPβ的表达。(4)进一步用ChIP和EMSA技术研究发现,白细胞介素-1β促进C/EBPβ与11β-HSD1启动子CCAAT序列的结合。
(5)转染表达C/EBPβ质粒(pMSV-C/EBPβ)和表达拮抗C/EBP蛋白的质粒(CMV-500-A-C/EBP)分别可以模拟和阻断白细胞介素-1β对11β-HSD1表达的诱导作用。以上结果提示,白细胞介素-1β主要通过C/EBPβ诱导HFL-1细胞11β-HSD1的表达。
5.我们以原代培养的人羊膜成纤维细胞为模型进一步研究了皮质醇诱导11β-HSD1 mRNA表达的分子机制。结果表明：(1)皮质醇对11β-HSD1 mRNA表达的诱导作用能够被糖皮质激素受体拮抗剂RU486阻断,提示皮质醇诱导11β-HSD1表达的作用需要糖皮质激素受体的参与。(2)将11β-HSD1启动子-报告基因质粒转染细胞后测定其启动子活性发现,皮质醇能够促进人羊膜成纤维细胞11β-HSD1启动子活性增加,此作用可以分别被糖皮质激素反应元件(GRE)和CCAAT序列突变所削弱。(3)Western blotting分析结果表明,人羊膜成纤维细胞中主要表达C/EBPa而少量表达C/EBPp,皮质醇对人羊膜成纤维细胞C/EBPa表达的诱导作用比较明显。(4)进一步用ChIP和EMSA技术研究发现,皮质醇促进GRα和C/EBPa分别与11β-HSD1启动子的GRE和CCAAT序列的结合。(5)转染CMV-500-A-C/EBP质粒可以削弱皮质醇对11β-HSD1表达的诱导作用。以上结果提示,糖皮质激素受体和C/EBPa都参与了皮质醇对人羊膜成纤维细胞11β-HSD1表达的诱导作用。
结论本课题研究结果表明,妊娠晚期人胎肺组织中表达11β-HSD1;白细胞介素-1β与皮质醇诱导11β-HSD1基因表达的现象同时存在于HFL-1细胞和人羊膜成纤维细胞。皮质醇主要通过促进糖皮质激素受体GRα和C/EBPa分别与11β-HSD1基因启动子糖皮质激素反应元件和C/EBP结合位点的结合诱导人羊膜成纤维细胞11β-HSD1基因表达；白细胞介素-1β主要通过促进C/EBPp与11β-HSD1基因启动子上C/EBP结合位点的结合诱导HFL-1细胞11β-HSD1基因表达。C/EBPs可能是皮质醇与白介素-1β诱导11β-HSD1基因表达的共同分子节点。
Context and Aims:
Synchronization of fetal maturation, especially the lung maturation, and initiation of parturition is crucial for the survival of the newborn. Accumulating evidences suggest that increased glucocorticoid level towards the end of gestation triggers both of the events. Due to the unique structure of the fetal adrenal and the existence of placental glucocorticoid barrier, the regeneration of cortisol from cortisone by 11β-hydroxysteroid dehydrogenase type 1 (11(3-HSD1) in the fetal tissue plays a significant role in elevating the local level of glucocorticoids within the tissues. Substantial evidence indicated the presence of 11β-HSD1 in most of the animal fetal lung tissues. Furthermore, 11β-HSD1-/- mice exhibit impaired fetal lung maturation, suggesting the crucial role of 11β-HSD1 in fetal lung maturation. However, the expression of 11β-HSD1 in human fetal lung remains controversial. In addition to the glucocorticoid regeneration by the fetal organ per se, glucocorticoids derived from 11β-HSD1 in the fetal membranes is believed to be another important extra-adrenal source of fetal cortisol in late gestation. Of interest, up-regulation of 11β-HSD1 by proinflammatory cytokines and anti-inflammatory glucocorticoids has been reported in the fetal membranes; however, the molecular mechanism underlying this intriguing up-regulation of 11β-HSD1 by proinflammatory cytokines and glucocorticoids remains largely unknown. In this study, we investigated the expression of 11β-HSD1 in human fetal lung tissues and examined whether the up-regulation of 11β-HSD1 by proinflammatory cytokines and glucocorticoids also holds true in the fetal lung cells. Based on these findings, we investigated the molecular mechanisms underlying the induction of 11 P-HSD1 by Interlukin-1β(IL-1β) and cortisol in human fetal lung fibroblast cell line (HFL-1) and primary human amnion fibroblasts respectively. Elucidation of these mechanisms may help us to understand better the process of human fetal lung maturation.
Methods and Results:
1. Regular PCR and immunohistochemistry revealed that 11β-HSD1 mRNA was detectable in the fetal lung tissues both at 8 and 4 months of gestation, but 11β-HSD1 protein was only detected in the fetal lung tissue at 8 months of gestation. Positive immunostaining for 11β-HSD1 was found in the epithelium lining the small bronchus, bronchiole and in the fibroblast-enriched mesenchymal tissue of the small bronchus. The detection of 11β-HSD1 mRNA, protein and enzyme activity in HFL-1 cells lends further support for the expression of 11β-HSD1 in human fetal lung. Meanwhile, our findings also indicate that HFL-1 cell is a good model for the further study of the regulation of 11β-HSD1 expression.
2. By using real-time PCR, Western blotting and enzyme activity assay, we demonstrated that IL-1βand cortisol induced 11β-HSD1 expression in HFL-1 cells as well as in human amnion fibroblasts.
3.Further studies with real-time PCR illustrated that the induction of 11β-HSD1 in HFL-1 cells and human amnion fibroblasts by both IL-1βand cortisol could be blocked by the messenger RNA transcription inhibitor DRB and the protein synthesis inhibitor CHX, suggesting that the induction is dependent on ongoing transcription and synthesis of at least one other protein. Of interest, the induction of 117β-HSD1 in HFL-1 cells and human amnion fibroblasts by both IL-1βand cortisol could also be blocked by transfection of CMV-500-A-C/EBP which expresses dominant negative C/EBP, suggesting that C/EBPs might be involved in the induction of 11β-HSD1 by both IL-1βand cortisol in both HFL-1 cells and human amnion fibroblasts.
4. We further studied molecular mechanisms of the induction of 11β-HSD1 by IL-1βin HFL-1 cells. We found that:(1) NF-kB transactivation inhibitor 5HPP-33 could block IL-1β-induced COX-2 expression but not 11β-HSD1 expression, suggesting a unique pathway underlying the induction of 11β-HSD1 by IL-1β, which differs from the classical pro-inflammatory signaling pathway. (2) Reporter gene assay demonstrated that IL-1βstimulated 11β-HSD1 promoter activity, which was attenuated by mutagenesis of a C/EBP binding site in the promoter. (3) Western blotting results illustrated that HFL-1 cells expressed barely detectable C/EBPa but high level of C/EBPβthat could be induced dramatically by IL-1β. (4) C/EBPβwas found bound to the putative C/EBP binding site in 11β-HSD1 promoter upon IL-1βstimulation of HFL-1 cells with ChIP and EMSA. (5) Transfection of pMSV-C/EBPβplasmid over-expressing C/EBPβor CMV-500-A-C/EBP could mimic or antagonize the induction of 11β-HSD1 by IL-1β. The above results indicate that the induction of 11β-HSDl gene expression by IL-1βdepends on the activation of C/EBPβbinding to the CCAAT box in the promoter in HFL-1 cells.
5. The molecular mechanisms underlying the induction of 11β-HSD1 by cortisol were further investigated in primary human amnion fibroblasts. Results showed that:(1) The induction of 11β-HSD1 by cortisol could be blocked by GR antagonist RU486, suggesting the induction is a GR-dependent process. (2) Report gene assay demonstrated that the induction of 11β-HSD1 promoter activity by cortisol was attenuated by mutagenesis of a glucocorticoid response element (GRE) and a CCAAT consensus sequence in the promoter, respectively. (3) Western blotting illustrated that human amnion fibroblasts expressed low C/EBPβbut high C/EBPαlevel that can be increased by cortisol. (4) ChIP and EMSA demonstrated that both GRαand C/EBPαcould bind the GRE and C/EBP binding site upon cortisol stimulation of human amnion fibroblasts (5) The induction of 11β-HSD1 by cortisol could be blocked by transfection of CMV-500-A-C/EBP. All these results lead to the conclusions that induction of 11β-HSD1 gene expression by cortisol involves both activation of GRαand C/EBPαbinding to the promoter in human amnion fibroblasts.
Conclusions:
11β-HSD1 is expressed in human fetal lung tissue at least at later gestation. The induction of 11β-HSD1 by IL-1βand cortisol holds true in HFL-1 cells as well as in primary human amnion fibroblasts. The induction of 11β-HSD1 gene expression by IL-1βdepends on the activation of C/EBPβbinding to the CCAAT box in the promoter in HFL-1 cells, while the induction of 11β-HSD1 gene expression by cortisol involves both activation of GRαand C/EBPαbinding to the promoter in human amnion fibroblasts. Based upon all these findings, we propose that C/EBPs be the key transcription factors involved in the induction of 11β-HSD1 by both IL-1βand cortisol.
1.常规PCR和免疫组织化学染色结果表明,妊娠中期(孕4个月)和晚期(孕8个月)人胎肺组织中都能够检测到11β-HSD1 mRNA,但只在妊娠晚期胎肺组织中检测到11β-HSD1的分布,包括小支气管和细支气管的上皮细胞和小支气管间质细胞。此外,在HFL-1细胞中也检测到了11β-HSD1mRNA和蛋白,而且用Western blotting和酶活性测定的方法证实了上述结果。此结果不但提示胎儿肺组织至少在妊娠晚期可以表达11β-HSD1蛋白,而且也提示HFL-1细胞是进一步研究胎儿肺11β-HSD1表达调控的良好实验模型。
2.以HFL-1细胞和原代培养的人羊膜成纤维细胞为研究模型,用实时荧光定量PCR、Western blotting和酶活性测定等方法研究发现,白细胞介素-1β与皮质醇增加11β-HSD1 mRNA和蛋白水平的现象同时存在于HFL-1细胞和原代培养的人羊膜成纤维细胞中。
3.实时荧光定量PCR测定结果表明,白细胞介素-1β与皮质醇对人羊膜成纤维细胞和HFL-1细胞11β-HSD1 mRNA表达的诱导作用能够被mRNA转录抑制剂DRB和蛋白质合成抑制剂CHX阻断,提示白细胞介素-1β与皮质醇增加11β-HSD1mRNA水平的作用发生在转录水平并需要蛋白质合成的参与。用表达拮抗C/EBP蛋白的质粒(CMV-500-A-C/EBP)转染HFL-1细胞和人羊膜成纤维细胞发现,白细胞介素-1β与皮质醇诱导11β-HSD1 mRNA表达作用均可以被不同程度阻断,提示在上述两种细胞中C/EBPs家族成员均参与了白细胞介素-1β与皮质醇诱导11β-HSD1 mRNA表达作用。
4.我们以HFL-1细胞为模型进一步研究了白细胞介素-1β诱导11β-HSD1 mRNA表达的分子机制。结果表明：(1)NF-kB转录激活抑制剂5HPP-33不能阻断白细胞介素-1β对HFL-1细胞11β-HSD1 mRNA表达的诱导作用,但能够阻断白细胞介素-1β对炎症介质前列腺素合成酶COX-2 mRNA的诱导作用,提示白细胞介素-1β对11β-HSD1 mRNA表达的促进作用与此经典的炎症通路无关。(2)将11β-HSD1启动子克隆并构建于报告基因质粒,转染HFL-1细胞后测定其启动子活性发现,白细胞介素-1β能够促进11β-HSD1启动子活性增加,此作用可以被CCAAT序列突变所阻断。(3)Western blotting分析结果表明,HFL-1细胞中主要表达C/EBPβ而几乎不表达C/EBPα,白细胞介素-1β强烈诱导C/EBPβ的表达。(4)进一步用ChIP和EMSA技术研究发现,白细胞介素-1β促进C/EBPβ与11β-HSD1启动子CCAAT序列的结合。
(5)转染表达C/EBPβ质粒(pMSV-C/EBPβ)和表达拮抗C/EBP蛋白的质粒(CMV-500-A-C/EBP)分别可以模拟和阻断白细胞介素-1β对11β-HSD1表达的诱导作用。以上结果提示,白细胞介素-1β主要通过C/EBPβ诱导HFL-1细胞11β-HSD1的表达。
5.我们以原代培养的人羊膜成纤维细胞为模型进一步研究了皮质醇诱导11β-HSD1 mRNA表达的分子机制。结果表明：(1)皮质醇对11β-HSD1 mRNA表达的诱导作用能够被糖皮质激素受体拮抗剂RU486阻断,提示皮质醇诱导11β-HSD1表达的作用需要糖皮质激素受体的参与。(2)将11β-HSD1启动子-报告基因质粒转染细胞后测定其启动子活性发现,皮质醇能够促进人羊膜成纤维细胞11β-HSD1启动子活性增加,此作用可以分别被糖皮质激素反应元件(GRE)和CCAAT序列突变所削弱。(3)Western blotting分析结果表明,人羊膜成纤维细胞中主要表达C/EBPa而少量表达C/EBPp,皮质醇对人羊膜成纤维细胞C/EBPa表达的诱导作用比较明显。(4)进一步用ChIP和EMSA技术研究发现,皮质醇促进GRα和C/EBPa分别与11β-HSD1启动子的GRE和CCAAT序列的结合。(5)转染CMV-500-A-C/EBP质粒可以削弱皮质醇对11β-HSD1表达的诱导作用。以上结果提示,糖皮质激素受体和C/EBPa都参与了皮质醇对人羊膜成纤维细胞11β-HSD1表达的诱导作用。
结论本课题研究结果表明,妊娠晚期人胎肺组织中表达11β-HSD1;白细胞介素-1β与皮质醇诱导11β-HSD1基因表达的现象同时存在于HFL-1细胞和人羊膜成纤维细胞。皮质醇主要通过促进糖皮质激素受体GRα和C/EBPa分别与11β-HSD1基因启动子糖皮质激素反应元件和C/EBP结合位点的结合诱导人羊膜成纤维细胞11β-HSD1基因表达；白细胞介素-1β主要通过促进C/EBPp与11β-HSD1基因启动子上C/EBP结合位点的结合诱导HFL-1细胞11β-HSD1基因表达。C/EBPs可能是皮质醇与白介素-1β诱导11β-HSD1基因表达的共同分子节点。
Context and Aims:
Synchronization of fetal maturation, especially the lung maturation, and initiation of parturition is crucial for the survival of the newborn. Accumulating evidences suggest that increased glucocorticoid level towards the end of gestation triggers both of the events. Due to the unique structure of the fetal adrenal and the existence of placental glucocorticoid barrier, the regeneration of cortisol from cortisone by 11β-hydroxysteroid dehydrogenase type 1 (11(3-HSD1) in the fetal tissue plays a significant role in elevating the local level of glucocorticoids within the tissues. Substantial evidence indicated the presence of 11β-HSD1 in most of the animal fetal lung tissues. Furthermore, 11β-HSD1-/- mice exhibit impaired fetal lung maturation, suggesting the crucial role of 11β-HSD1 in fetal lung maturation. However, the expression of 11β-HSD1 in human fetal lung remains controversial. In addition to the glucocorticoid regeneration by the fetal organ per se, glucocorticoids derived from 11β-HSD1 in the fetal membranes is believed to be another important extra-adrenal source of fetal cortisol in late gestation. Of interest, up-regulation of 11β-HSD1 by proinflammatory cytokines and anti-inflammatory glucocorticoids has been reported in the fetal membranes; however, the molecular mechanism underlying this intriguing up-regulation of 11β-HSD1 by proinflammatory cytokines and glucocorticoids remains largely unknown. In this study, we investigated the expression of 11β-HSD1 in human fetal lung tissues and examined whether the up-regulation of 11β-HSD1 by proinflammatory cytokines and glucocorticoids also holds true in the fetal lung cells. Based on these findings, we investigated the molecular mechanisms underlying the induction of 11 P-HSD1 by Interlukin-1β(IL-1β) and cortisol in human fetal lung fibroblast cell line (HFL-1) and primary human amnion fibroblasts respectively. Elucidation of these mechanisms may help us to understand better the process of human fetal lung maturation.
Methods and Results:
1. Regular PCR and immunohistochemistry revealed that 11β-HSD1 mRNA was detectable in the fetal lung tissues both at 8 and 4 months of gestation, but 11β-HSD1 protein was only detected in the fetal lung tissue at 8 months of gestation. Positive immunostaining for 11β-HSD1 was found in the epithelium lining the small bronchus, bronchiole and in the fibroblast-enriched mesenchymal tissue of the small bronchus. The detection of 11β-HSD1 mRNA, protein and enzyme activity in HFL-1 cells lends further support for the expression of 11β-HSD1 in human fetal lung. Meanwhile, our findings also indicate that HFL-1 cell is a good model for the further study of the regulation of 11β-HSD1 expression.
2. By using real-time PCR, Western blotting and enzyme activity assay, we demonstrated that IL-1βand cortisol induced 11β-HSD1 expression in HFL-1 cells as well as in human amnion fibroblasts.
3.Further studies with real-time PCR illustrated that the induction of 11β-HSD1 in HFL-1 cells and human amnion fibroblasts by both IL-1βand cortisol could be blocked by the messenger RNA transcription inhibitor DRB and the protein synthesis inhibitor CHX, suggesting that the induction is dependent on ongoing transcription and synthesis of at least one other protein. Of interest, the induction of 117β-HSD1 in HFL-1 cells and human amnion fibroblasts by both IL-1βand cortisol could also be blocked by transfection of CMV-500-A-C/EBP which expresses dominant negative C/EBP, suggesting that C/EBPs might be involved in the induction of 11β-HSD1 by both IL-1βand cortisol in both HFL-1 cells and human amnion fibroblasts.
4. We further studied molecular mechanisms of the induction of 11β-HSD1 by IL-1βin HFL-1 cells. We found that:(1) NF-kB transactivation inhibitor 5HPP-33 could block IL-1β-induced COX-2 expression but not 11β-HSD1 expression, suggesting a unique pathway underlying the induction of 11β-HSD1 by IL-1β, which differs from the classical pro-inflammatory signaling pathway. (2) Reporter gene assay demonstrated that IL-1βstimulated 11β-HSD1 promoter activity, which was attenuated by mutagenesis of a C/EBP binding site in the promoter. (3) Western blotting results illustrated that HFL-1 cells expressed barely detectable C/EBPa but high level of C/EBPβthat could be induced dramatically by IL-1β. (4) C/EBPβwas found bound to the putative C/EBP binding site in 11β-HSD1 promoter upon IL-1βstimulation of HFL-1 cells with ChIP and EMSA. (5) Transfection of pMSV-C/EBPβplasmid over-expressing C/EBPβor CMV-500-A-C/EBP could mimic or antagonize the induction of 11β-HSD1 by IL-1β. The above results indicate that the induction of 11β-HSDl gene expression by IL-1βdepends on the activation of C/EBPβbinding to the CCAAT box in the promoter in HFL-1 cells.
5. The molecular mechanisms underlying the induction of 11β-HSD1 by cortisol were further investigated in primary human amnion fibroblasts. Results showed that:(1) The induction of 11β-HSD1 by cortisol could be blocked by GR antagonist RU486, suggesting the induction is a GR-dependent process. (2) Report gene assay demonstrated that the induction of 11β-HSD1 promoter activity by cortisol was attenuated by mutagenesis of a glucocorticoid response element (GRE) and a CCAAT consensus sequence in the promoter, respectively. (3) Western blotting illustrated that human amnion fibroblasts expressed low C/EBPβbut high C/EBPαlevel that can be increased by cortisol. (4) ChIP and EMSA demonstrated that both GRαand C/EBPαcould bind the GRE and C/EBP binding site upon cortisol stimulation of human amnion fibroblasts (5) The induction of 11β-HSD1 by cortisol could be blocked by transfection of CMV-500-A-C/EBP. All these results lead to the conclusions that induction of 11β-HSD1 gene expression by cortisol involves both activation of GRαand C/EBPαbinding to the promoter in human amnion fibroblasts.
Conclusions:
11β-HSD1 is expressed in human fetal lung tissue at least at later gestation. The induction of 11β-HSD1 by IL-1βand cortisol holds true in HFL-1 cells as well as in primary human amnion fibroblasts. The induction of 11β-HSD1 gene expression by IL-1βdepends on the activation of C/EBPβbinding to the CCAAT box in the promoter in HFL-1 cells, while the induction of 11β-HSD1 gene expression by cortisol involves both activation of GRαand C/EBPαbinding to the promoter in human amnion fibroblasts. Based upon all these findings, we propose that C/EBPs be the key transcription factors involved in the induction of 11β-HSD1 by both IL-1βand cortisol.
引文
[1]. Wood WG, Pearce K, Clegg JB, Weatherall DJ, Robinson JS, Thorburn GD, Dawes GS. Switch from foetal to adult haemoglobin synthesis in normal and hypophysectomised sheep [J]. Nature.1976;264(5588):799-801.
[2]. Young IR, Thorburn GD. Prostaglandin E2, fetal maturation and ovine parturition [J]. Aust N Z J Obstet Gynaecol.1994;34(3):342-346.
[3]. Currie WB, Thorburn GD. The fetal role in timing the initiation of parturition in the goat [J]. Ciba Found Symp.1977(47):49-72.
[4]. Walfisch A, Hallak M, Mazor M. Multiple courses of antenatal steroids:risks and benefits [J]. Obstet Gynecol.2001;98(3):491-497.
[5]. Crowley P. Prophylactic corticosteroids for preterm birth [J]. Cochrane Database Syst Rev.2000(2):CD000065.
[6]. Challis JR, Lye SJ. Parturition [J]. Oxf Rev Reprod Biol.1986;8:61-129.
[7]. Bassett JM, Thorburn GD. Foetal plasma corticosteroids and the initiation of parturition in sheep [J]. J Endocrinol.1969;44(2):285-286.
[8]. Liley HG, Ertsey R, Gonzales LW, Odom MW, Hawgood S, Dobbs LG, Ballard PL. Synthesis of surfactant components by cultured type II cells from human lung [J]. Biochim Biophys Acta.1988;961(1):86-95.
[9]. Maniscalco WM, Shapiro DL. Effects of dexamethasone on beta-adrenergic receptors in fetal lung explants [J]. Pediatr Res.1983;17(4):274-277.
[10]. Liley HG, White RT, Benson BJ, Ballard PL. Glucocorticoids both stimulate and inhibit production of pulmonary surfactant protein A in fetal human lung [J]. Proc Natl Acad Sci U S A.1988;85(23):9096-9100.
[11]. Ballard PL, Ertsey R, Gonzales LW, Gonzales J. Transcriptional regulation of human pulmonary surfactant proteins SP-B and SP-C by glucocorticoids [J]. Am J Respir Cell Mol Biol.1996;14(6):599-607.
[12]. Mariencheck W, Crouch E. Modulation of surfactant protein D expression by glucocorticoids in fetal rat lung [J]. Am J Respir Cell Mol Biol. 1994; 10(4):419-429.
[13]. Dulkerian SJ, Gonzales LW, Ning Y, Ballard PL. Regulation of surfactant protein D in human fetal lung [J]. Am J Respir Cell Mol Biol. 1996; 15(6):781-786.
[14]. Xu J, Possmayer F. Exposure of rabbit fetal lung to glucocorticoids in vitro does not enhance transcription of the gene encoding pulmonary surfactant-associated protein-B (SP-B) [J]. Biochim Biophys Acta. 1993;1169(2):146-155.
[15]. Post M. Maternal administration of dexamethasone stimulates choline-phosphate cytidylyltransferase in fetal type Ⅱ cells [J]. Biochem J. 1987;241(1):291-296.
[16]. Sharma A, Gonzales LW, Ballard PL. Hormonal regulation of cholinephosphate cytidylyltransferase in human fetal lung [J]. Biochim Biophys Acta.1993;1170(3):237-244.
[17]. Rooney SA, Smart DA, Weinhold PA, Feldman DA. Dexamethasone increases the activity but not the amount of choline-phosphate cytidylyltransferase in fetal rat lung [J]. Biochim Biophys Acta.1990;1044(3):385-389.
[18]. Guttentag SH, Beers MF, Bieler BM, Ballard PL. Surfactant protein B processing in human fetal lung [J]. Am J Physiol.1998;275(3 Pt 1):L559-566.
[19]. Solarin KO, Ballard PL, Guttentag SH, Lomax CA, Beers MF. Expression and glucocorticoid regulation of surfactant protein C in human fetal lung [J]. Pediatr Res.1997;42(3):356-364.
[20]. Pierce RA, Mariencheck WI, Sandefur S, Crouch EC, Parks WC. Glucocorticoids upregulate tropoelastin expression during late stages of fetal lung development [J]. Am J Physiol.1995;268(3 Pt 1):L491-500.
[21]. Yee W, Wang J, Liu J, Tseu I, Kuliszewski M, Post M. Glucocorticoid-induced tropoelastin expression is mediated via transforming growth factor-beta 3 [J]. Am J Physiol.1996;270(6Pt 1):L992-1001.
[22]. Schellenberg JC, Liggins GC, Stewart AW. Growth, elastin concentration, and collagen concentration of perinatal rat lung:effects of dexamethasone [J]. Pediatr Res.1987;21(6):603-607.
[23]. Ledo I, Wu M, Katchman S, Brown D, Kennedy S, Hsu-Wong S, Uitto J. Glucocorticosteroids up-regulate human elastin gene promoter activity in transgenic mice [J]. J Invest Dermatol.1994;103(5):632-636.
[24]. Tchepichev S, Ueda J, Canessa C, Rossier BC, O'Brodovich H. Lung epithelial Na channel subunits are differentially regulated during development and by steroids [J]. Am J Physiol.1995;269(3 Pt 1):C805-812.
[25]. Ingbar DH, Duvick S, Savick SK, Schellhase DE, Detterding R, Jamieson JD, Shannon JM. Developmental changes of fetal rat lung Na-K-ATPase after maternal treatment with dexamethasone [J]. Am J Physiol.1997;272(4 Pt 1):L665-672.
[26]. King LS, Nielsen S, Agre P. Aquaporin-1 water channel protein in lung: ontogeny, steroid-induced expression, and distribution in rat [J]. J Clin Invest. 1996;97(10):2183-2191.
[27]. Giannopoulos G, Smith SK. Hormonal regulation of beta-adrenergic receptors in fetal rabbit lung in organ culture [J]. Life Sci.1982;31(8):795-802.
[28]. Cheng JB, Goldfien A, Ballard PL, Roberts JM. Glucocorticoids increase pulmonary beta-adrenergic receptors in fetal rabbit [J]. Endocrinology. 1980; 107(5):1646-1648.
[29]. Barnes P, Jacobs M, Roberts JM. Glucocorticoids preferentially increase fetal alveolar beta-adrenoreceptors:autoradiographic evidence [J]. Pediatr Res. 1984;18(11):1191-1194.
[30]. Frank L, Lewis PL, Sosenko IR. Dexamethasone stimulation of fetal rat lung antioxidant enzyme activity in parallel with surfactant stimulation [J]. Pediatrics.1985;75(3):569-574.
[31]. Randhawa P, Hass M, Frank L, Massaro D. Dexamethasone increases superoxide dismutase activity in serum-free rat fetal lung organ cultures [J]. Pediatr Res.1986;20(9):895-898.
[32]. Clerch LB, Iqbal J, Massaro D. Perinatal rat lung catalase gene expression: influence of corticosteroid and hyperoxia [J]. Am J Physiol.1991;260(6 Pt 1):L428-433.
[33]. Liggins GC. Premature parturition after infusion of corticotrophin or cortisol into foetal lambs [J]. J Endocrinol.1968;42(2):323-329.
[34]. Liggins GC. Premature delivery of foetal lambs infused with glucocorticoids [J]. J Endocrinol.1969;45(4):515-523.
[35]. McLean M, Bisits A, Davies J, Woods R, Lowry P, Smith R. A placental clock controlling the length of human pregnancy [J]. Nat Med.1995;1(5):460-463.
[36]. Sandman CA, Glynn L, Schetter CD, Wadhwa P, Garite T, Chicz-DeMet A, Hobel C. Elevated maternal cortisol early in pregnancy predicts third trimester levels of placental corticotropin releasing hormone (CRH):priming the placental clock [J]. Peptides.2006;27(6):1457-1463.
[37]. Jones SA, Brooks AN, Challis JR. Steroids modulate corticotropin-releasing hormone production in human fetal membranes and placenta [J]. J Clin Endocrinol Metab.1989;68(4):825-830.
[38]. Newman SP, Flower RJ, Croxtall JD. Dexamethasone suppression of 1L-1 beta-induced cyclooxygenase 2 expression is not mediated by lipocortin-1 in A549 cells [J]. Biochem Biophys Res Commun.1994;202(2):931-939.
[39]. DeWitt DL, Meade EA. Serum and glucocorticoid regulation of gene transcription and expression of the prostaglandin H synthase-1 and prostaglandin H synthase-2 isozymes [J]. Arch Biochem Biophys. 1993;306(1):94-102.
[40]. Samet JM, Fasano MB, Fonteh AN, Chilton FH. Selective induction of prostaglandin G/H synthase I by stem cell factor and dexamethasone in mast cells [J]. J Biol Chem.1995;270(14):8044-8049.
[41]. Potestio FA, Zakar T, Olson DM. Glucocorticoids stimulate prostaglandin synthesis in human amnion cells by a receptor-mediated mechanism [J]. J Clin Endocrinol Metab.1988;67(6):1205-1210.
[42]. Patel FA, Clifton VL, Chwalisz K, Challis JR. Steroid regulation of prostaglandin dehydrogenase activity and expression in human term placenta and chorio-decidua in relation to labor [J]. J Clin Endocrinol Metab. 1999;84(1):291-299.
[43]. Sun K, Adamson SL, Yang K, Challis JR. Interconversion of cortisol and cortisone by 11 beta-hydroxysteroid dehydrogenases type 1 and 2 in the perfused human placenta [J]. Placenta.1999;20(1):13-19.
[44]. Sun K, Yang K, Challis JR. Regulation of 11beta-hydroxysteroid dehydrogenase type 2 by progesterone, estrogen, and the cyclic adenosine 5'-monophosphate pathway in cultured human placental and chorionic trophoblasts [J]. Biol Reprod.1998;58(6):1379-1384.
[45]. Condon JC, Jeyasuria P, Faust JM, Mendelson CR. Surfactant protein secreted by the maturing mouse fetal lung acts as a hormone that signals the initiation of parturition [J]. Proc Natl Acad Sci U S A.2004;101(14):4978-4983.
[46]. Ballard PL, Kitterman JA, Bland RD, Clyman RI, Gluckman PD, Platzker AC, Kaplan SL, Grumbach MM. Ontogeny and regulation of corticosteroid binding globulin capacity in plasma of fetal and newborn lambs [J]. Endocrinology.1982;110(2):359-366.
[47]. Fairclough RJ, Liggins GC. Protein binding of plasma cortisol in the foetal lamb near term [J]. J Endocrinol.1975;67(3):333-341.
[48]. Edwards CR, Benediktsson R, Lindsay RS, Seckl JR.11 beta-Hydroxysteroid dehydrogenases:key enzymes in determining tissue-specific glucocorticoid effects [J]. Steroids.1996;61(4):263-269.
[49]. Diederich S, Eigendorff E, Burkhardt P, Quinkler M, Bumke-Vogt C, Rochel M, Seidelmann D, Esperling P, Oelkers W, Bahr V. llbeta-hydroxysteroid dehydrogenase types 1 and 2:an important pharmacokinetic determinant for the activity of synthetic mineralo-and glucocorticoids [J]. J Clin Endocrinol Metab.2002;87(12):5695-5701.
[50]. Draper N, Stewart PM. 11beta-hydroxysteroid dehydrogenase and the pre-receptor regulation of corticosteroid hormone action [J]. J Endocrinol. 2005;186(2):251-271.
[51]. Tomlinson JW, Walker EA, Bujalska IJ, Draper N, Lavery GG, Cooper MS, Hewison M, Stewart PM. llbeta-hydroxysteroid dehydrogenase type 1:a tissue-specific regulator of glucocorticoid response [J]. Endocr Rev. 2004;25(5):831-866.
[52]. Michael AE, Thurston LM, Rae MT. Glucocorticoid metabolism and reproduction:a tale of two enzymes [J]. Reproduction.2003;126(4):425-441.
[53]. Hundertmark S, Dill A, Ebert A, Zimmermann B, Kotelevtsev YV, Mullins JJ, Seckl JR. Foetal lung maturation in 11beta-hydroxysteroid dehydrogenase type 1 knockout mice [J]. Horm Metab Res.2002;34(10):545-549.
[54]. Alfaidy N, Li W, MacIntosh T, Yang K, Challis J. Late gestation increase in 11beta-hydroxysteroid dehydrogenase 1 expression in human fetal membranes: a novel intrauterine source of cortisol [J]. J Clin Endocrinol Metab. 2003;88(10):5033-5038.
[55]. Stewart PM, Murry BA, Mason JI. Type 2 11 beta-hydroxysteroid dehydrogenase in human fetal tissues [J]. J Clin Endocrinol Metab. 1994;78(6):1529-1532.
[56]. Pasqualini JR, Marfil J, Gamier F, Wiqvist N, Diczfalusy E. Studies on the metabolism of corticosteroids in the human foeto-placental unit.4. Metabolism of deoxycorticosterone and corticosterone administered simultaneously into the intact umbilical circulation [J]. Acta Endocrinol (Copenh).1970;64(3):385-397.
[57]. Smith BT, Torday JS, Giroud CJ. The growth promoting effect of cortisol on human fetal lung cells [J]. Steroids.1973;22(4):515-524.
[58]. Tannin GM, Agarwal AK, Monder C, New MI, White PC. The human gene for 11 beta-hydroxysteroid dehydrogenase. Structure, tissue distribution, and chromosomal localization [J]. J Biol Chem.1991;266(25):16653-16658.
[59]. Page N, Warriar N, Govindan MV.11 beta-hydroxysteroid dehydrogenase activity in human lung cells and transcription regulation by glucocorticoids [J]. Am J Physiol.1994;267(4 Pt 1):L464-474.
[60]. Soldan M, Nagel G, Losekam M, Ernst M, Maser E. Interindividual variability in the expression and NNK carbonyl reductase activity of 11 beta-hydroxysteroid dehydrogenase 1 in human lung [J]. Cancer Lett. 1999;145(1-2):49-56.
[61]. Finckh C, Atalla A, Nagel G, Stinner B, Maser E. Expression and NNK reducing activities of carbonyl reductase and 11beta-hydroxysteroid dehydrogenase type 1 in human lung [J]. Chem Biol Interact. 2001;130-132(1-3):761-773.
[62]. Sun K, He P, Yang K. Intracrine induction of 11beta-hydroxysteroid dehydrogenase type 1 expression by glucocorticoid potentiates prostaglandin production in the human chorionic trophoblast [J]. Biol Reprod. 2002;67(5):1450-1455.
[63]. Sun K, Myatt L. Enhancement of glucocorticoid-induced 11 beta-hydroxysteroid dehydrogenase type 1 expression by proinflammatory cytokines in cultured human amnion fibroblasts [J]. Endocrinology. 2003;144(12):5568-5577.
[64]. Draper N, Echwald SM, Lavery GG, Walker EA, Fraser R, Davies E, Sorensen TI, Astrup A, Adamski J, Hewison M, Connell JM, Pedersen O, Stewart PM. Association studies between microsatellite markers within the gene encoding human 11beta-hydroxysteroid dehydrogenase type 1 and body mass index, waist to hip ratio, and glucocorticoid metabolism [J]. J Clin Endocrinol Metab. 2002;87(11):4984-4990.
[65]. Heitzer MD, Wolf IM, Sanchez ER, Witchel SF, DeFranco DB. Glucocorticoid receptor physiology [J]. Rev Endocr Metab Disord.2007;8(4):321-330.
[66]. Munck A, Brinck-Johnsen T. Specific and nonspecific physicochemical interactions of glucocorticoids and related steroids with rat thymus cells in vitro [J]. J Biol Chem.1968;243(21):5556-5565.
[67]. Hollenberg SM, Weinberger C, Ong ES, Cerelli G, Oro A, Lebo R, Thompson EB, Rosenfeld MG, Evans RM. Primary structure and expression of a functional human glucocorticoid receptor cDNA [J]. Nature. 1985;318(6047):635-641.
[68]. Ito K, Barnes PJ, Adcock IM. Glucocorticoid receptor recruitment of histone deacetylase 2 inhibits interleukin-1beta-induced histone H4 acetylation on lysines 8 and 12 [J]. Mol Cell Biol.2000;20(18):6891-6903.
[69]. Gottlicher M, Heck S, Herrlich P. Transcriptional cross-talk, the second mode of steroid hormone receptor action [J]. J Mol Med.1998;76(7):480-489.
[70]. Akira S, Isshiki H, Sugita T, Tanabe O, Kinoshita S, Nishio Y, Nakajima T, Hirano T, Kishimoto T. A nuclear factor for 1L-6 expression (NF-IL6) is a member of a C/EBP family [J].EMBOJ.1990;9(6):1897-1906.
[71]. Poli V, Mancini FP, Cortese R. IL-6DBP, a nuclear protein involved in interleukin-6 signal transduction, defines a new family of leucine zipper proteins related to C/EBP [J]. Cell.1990;63(3):643-653.
[72]. Descombes P, Chojkier M, Lichtsteiner S, Falvey E, Schibler U. LAP, a novel member of the C/EBP gene family, encodes a liver-enriched transcriptional activator protein [J]. Genes Dev.1990;4(9):1541-1551.
[73]. Chang CJ, Chen TT, Lei HY, Chen DS, Lee SC. Molecular cloning of a transcription factor, AGP/EBP, that belongs to members of the C/EBP family [J]. Mol Cell Biol.1990;10(12):6642-6653.
[74]. Roman C, Platero JS, Shuman J, Calame K. Ig/EBP-1:a ubiquitously expressed immunoglobulin enhancer binding protein that is similar to C/EBP and heterodimerizes with C/EBP [J]. Genes Dev.1990;4(8):1404-1415.
[75]. Cao Z, Umek RM, McKnight SL. Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells [J]. Genes Dev. 1991;5(9):1538-1552.
[76]. Williams SC, Cantwell CA, Johnson PF. A family of C/EBP-related proteins capable of forming covalently linked leucine zipper dimers in vitro [J]. Genes Dev.1991;5(9):1553-1567.
[77]. Ron D, Habener JF. CHOP, a novel developmentally regulated nuclear protein that dimerizes with transcription factors C/EBP and LAP and functions as a dominant-negative inhibitor of gene transcription [J]. Genes Dev. 1992;6(3):439-453.
[78]. Ramji DP, Foka P. CCAAT/enhancer-binding proteins:structure, function and regulation [J]. Biochem J.2002;365(Pt 3):561-575.
[79]. Lekstrom-Himes J, Xanthopoulos KG. Biological role of the CCAAT/enhancer-binding protein family of transcription factors [J]. J Biol Chem.1998;273(44):28545-28548.
[80]. Wedel A, Ziegler-Heitbrock HW. The C/EBP family of transcription factors [J]. Immunobiology.1995;193(2-4):171-185.
[81]. Cardinaux JR, Allaman I, Magistretti PJ. Pro-inflammatory cytokines induce the transcription factors C/EBPbeta and C/EBPdelta in astrocytes [J]. Glia. 2000;29(1):91-97.
[82]. Tengku-Muhammad TS, Hughes TR, Ranki H, Cryer A, Ramji DP. Differential regulation of macrophage CCAAT-enhancer binding protein isoforms by lipopolysaccharide and cytokines [J]. Cytokine. 2000;12(9):1430-1436.
[83]. Granger RL, Hughes TR, Ramji DP. Stimulus-and cell-type-specific regulation of CCAAT-enhancer binding protein isoforms in glomerular mesangial cells by lipopolysaccharide and cytokines [J]. Biochim Biophys Acta.2000;1501(2-3):171-179.
[84]. Yin M, Yang SQ, Lin HZ, Lane MD, Chatterjee S, Diehl AM. Tumor necrosis factor alpha promotes nuclear localization of cytokine-inducible CCAAT/enhancer binding protein isoforms in hepatocytes [J]. J Biol Chem. 1996;271(30):17974-17978.
[85]. Buck M, Zhang L, Halasz NA, Hunter T, Chojkier M. Nuclear export of phosphorylated C/EBPbeta mediates the inhibition of albumin expression by TNF-alpha [J]. EMBO J.2001;20(23):6712-6723.
[86]. Timchenko N, Wilson DR, Taylor LR, Abdelsayed S, Wilde M, Sawadogo M, Darlington GJ. Autoregulation of the human C/EBP alpha gene by stimulation of upstream stimulatory factor binding [J]. Mol Cell Biol. 1995;15(3):1192-1202.
[87]. MacDougald OA, Cornelius P, Lin FT, Chen SS, Lane MD. Glucocorticoids reciprocally regulate expression of the CCAAT/enhancer-binding protein alpha and delta genes in 3T3-L1 adipocytes and white adipose tissue [J]. J Biol Chem.1994;269(29):19041-19047.
[88]. Rana B, Xie Y, Mischoulon D, Bucher NL, Farmer SR. The DNA binding activity of C/EBP transcription factor is regulated in the G1 phase of the hepatocyte cell cycle [J]. J Biol Chem.1995;270(30):18123-18132.
[89]. Stephens JM, Pekala PH. Transcriptional repression of the C/EBP-alpha and GLUT4 genes in 3T3-L1 adipocytes by tumor necrosis factor-alpha. Regulations is coordinate and independent of protein synthesis [J]. J Biol Chem.1992;267(19):13580-13584.
[90]. Mahoney CW, Shuman J, McKnight SL, Chen HC, Huang KP. Phosphorylation of CCAAT-enhancer binding protein by protein kinase C attenuates site-selective DNA binding [J]. J Biol Chem. 1992;267(27):19396-19403.
[91]. Iannuzzi DM, Ertsey R, Ballard PL. Biphasic glucocorticoid regulation of pulmonary SP-A:characterization of inhibitory process [J]. Am J Physiol. 1993;264(3Pt1):L236-244.
[92]. Karinch AM, Deiter G, Ballard PL, Floros J. Regulation of expression of human SP-A1 and SP-A2 genes in fetal lung explant culture [J]. Biochim Biophys Acta.1998; 1398(2):192-202.
[93]. Whitsett JA, Weaver TE, Clark JC, Sawtell N, Glasser SW, Korfhagen TR, Hull WM. Glucocorticoid enhances surfactant proteolipid Phe and pVal synthesis and RNA in fetal lung [J]. J Biol Chem.1987;262(32):15618-15623.
[94]. Venkatesh VC, Iannuzzi DM, Ertsey R, Ballard PL. Differential glucocorticoid regulation of the pulmonary hydrophobic surfactant proteins SP-B and SP-C [J]. Am J Respir Cell Mol Biol.1993;8(2):222-228.
[95]. Venkatesh VC, Planer BC, Schwartz M, Vanderbilt JN, White RT, Ballard PL. Characterization of the promoter of human pulmonary surfactant protein B gene [J]. Am J Physiol.1995;268(4 Pt 1):L674-682.
[96]. Brieu V, Cathiard AM, Darbeida H, Naaman E, Saez JM, Durand P. Development of the fetal pituitary-adrenal axis in the sheep [J]. Reprod Nutr Dev.1988;28(4B):1129-1144.
[97]. Naaman Reperant E, Durand P. The development of the ovine fetal adrenal gland and its regulation [J]. Reprod Nutr Dev.1997;37(1):81-95.
[98]. Gitau R, Fisk NM, Teixeira JM, Cameron A, Glover V. Fetal hypothalamic-pituitary-adrenal stress responses to invasive procedures are independent of maternal responses [J]. J Clin Endocrinol Metab. 2001;86(1):104-109.
[99]. Mesiano S, Jaffe RB. Developmental and functional biology of the primate fetal adrenal cortex [J]. Endocr Rev.1997;18(3):378-403.
[100]. Ballard PL, Ning Y, Polk D, Ikegami M, Jobe AH. Glucocorticoid regulation of surfactant components in immature lambs [J]. Am J Physiol.1997;273(5 Pt 1):L1048-1057.
[101]. Tan RC, Ikegami M, Jobe AH, Yao LY, Possmayer F, Ballard PL Developmental and glucocorticoid regulation of surfactant protein mRNAs in preterm lambs [J]. Am J Physiol.1999;277(6 Pt 1):L1142-1148.
[102]. Liggins GC, Kitterman JA, Campos GA, Clements JA, Forster CS, Lee CH, Creasy RK. Pulmonary maturation in the hypophysectomised ovine fetus. Differential responses to adrenocorticotrophin and cortisol [J]. J Dev Physiol. 1981;3(1):1-14.
[103]. Kitterman JA, Liggins GC, Campos GA, Clements JA, Forster CS, Lee CH, Creasy RK. Prepartum maturation of the lung in fetal sheep:relation to cortisol [J]. J Appl Physiol.1981;51(2):384-390.
[104]. Crone RK, Davies P, Liggins GC, Reid L. The effects of hypophysectomy, thyroidectomy, and postoperative infusion of cortisol or adrenocorticotrophin on the structure of the ovine fetal lung [J]. J Dev Physiol.1983;5(5):281-288.
[105]. Hitchcock KR. Hormones and the lung. I. Thyroid hormones and glucocorticoids in lung development [J]. Anat Rec.1979; 194(1):15-39.
[106]. Muglia L, Jacobson L, Dikkes P, Majzoub JA. Corticotropin-releasing hormone deficiency reveals major fetal but not adult glucocorticoid need [J]. Nature.1995;373(6513):427-432.
[107]. Cole TJ, Blendy JA, Monaghan AP, Krieglstein K, Schmid W, Aguzzi A, Fantuzzi G, Hummler E, Unsicker K, Schutz G. Targeted disruption of the glucocorticoid receptor gene blocks adrenergic chromaffin cell development and severely retards lung maturation [J]. Genes Dev.1995;9(13):1608-1621.
[108]. Kikkawa Y, Kaibara M, Motoyama EK, Orzalesi MM, Cook CD. Morphologic development of fetal rabbit lung and its acceleration with cortisol [J]. Am J Pathol.1971;64(2)::423-442.
[109]. Bunton TE, Plopper CG. Triamcinolone-induced structural alterations in the development of the lung of the fetal rhesus macaque [J]. Am J Obstet Gynecol. 1984;148(2):203-215.
[110]. Challis JR, Sloboda D, Matthews SG, Holloway A, Alfaidy N, Patel FA, Whittle W, Fraser M, Moss TJ, Newnham J. The fetal placental hypothalamic-pituitary-adrenal (HPA) axis, parturition and post natal health [J]. Mol Cell Endocrinol.2001;185(1-2):135-144.
[111]. Beitins IZ, Bayard F, Ances IG, Kowarski A, Migeon CJ. The metabolic clearance rate, blood production, interconversion and transplacental passage of cortisol and cortisone in pregnancy near term [J]. Pediatr Res. 1973;7(5):509-519.
[112]. Campbell AL, Murphy BE. The maternal-fetal cortisol gradient during pregnancy and at delivery [J]. J Clin Endocrinol Metab.1977;45(3):435-440.
[113]. Murphy BE, Clark SJ, Donald IR, Pinsky M, Vedady D. Conversion of maternal cortisol to cortisone during placental transfer to the human fetus [J]. Am J Obstet Gynecol.1974;118(4):538-541.
[114]. Bernal AL, Flint AP, Anderson AB, Turnbull AC.11 beta-Hydroxyteroid dehydrogenase activity (E.C.1.1.1.146) in human placenta and decidua [J]. J Steroid Biochem.1980;13(9):1081-1087.
[115]. de Fencl M, Tulchinsky D. Total cortisol in amniotic fluid and fetal lung maturation [J]. N Engl J Med.1975;292(3):133-136.
[116]. Sippell WG, Muller-Holve W, Dorr HG, Bidlingmaier F, Knorr D. Concentrations of aldosterone, corticosterone,11-deoxycorticosterone, progesterone,17-hydroxyprogesterone,11-deoxycortisol, cortisol, and cortisone determined simultaneously in human amniotic fluid throughout gestation [J]. J Clin Endocrinol Metab.1981;52(3):385-392.
[117]. Krozowski Z, Li KX, Koyama K, Smith RE, Obeyesekere VR, Stein-Oakley A, Sasano H, Coulter C, Cole T, Sheppard KE. The type Ⅰ and type Ⅱ 11beta-hydroxysteroid dehydrogenase enzymes [J]. J Steroid Biochem Mol Biol.1999;69(1-6):391-401.
[118]. Thompson A, Han VK, Yang K. Differential expression of 11beta-hydroxysteroid dehydrogenase types 1 and 2 mRNA and glucocorticoid receptor protein during mouse embryonic development [J]. J Steroid Biochem Mol Biol.2004;88(4-5):367-375.
[119]. Speirs HJ, Seckl JR, Brown RW. Ontogeny of glucocorticoid receptor and 11beta-hydroxysteroid dehydrogenase type-1 gene expression identifies potential critical periods of glucocorticoid susceptibility during development [J]. J Endocrinol.2004;181(1):105-116.
[120]. Hundertmark S, Dill A, Buhler H, Stevens P, Looman K, Ragosch V, Seckl JR, Lipka C.11 beta-hydroxysteroid dehydrogenase type 1:a new regulator of fetal lung maturation [J]. Horm Metab Res.2002;34(10):537-544.
[121]. Gnanalingham MG, Mostyn A, Gardner DS, Stephenson T, Symonds ME. Developmental regulation of the lung in preparation for life after birth: hormonal and nutritional manipulation of local glucocorticoid action and uncoupling protein-2 [J]. J Endocrinol.2006;188(3):375-386.
[122]. Krozowski Z, MaGuire JA, Stein-Oakley AN, Dowling J, Smith RE, Andrews RK. Immunohistochemical localization of the 11 beta-hydroxysteroid dehydrogenase type II enzyme in human kidney and placenta [J]. J Clin Endocrinol Metab.1995;80(7):2203-2209.
[123]. Albiston AL, Obeyesekere VR, Smith RE, Krozowski ZS. Cloning and tissue distribution of the human 11 beta-hydroxysteroid dehydrogenase type 2 enzyme [J]. Mol Cell Endocrinol.1994; 105(2):R11-17.
[124]. Shams M, Kilby MD, Somerset DA, Howie AJ, Gupta A, Wood PJ, Afnan M, Stewart PM.11 Beta-hydroxysteroid dehydrogenase type 2 in human pregnancy and reduced expression in intrauterine growth restriction [J]. Hum Reprod.1998;13(4):799-804.
[125]. Garbrecht MR, Schmidt TJ, Krozowski ZS, Snyder JM. 11 Beta-hydroxysteroid dehydrogenase type 2 and the regulation of surfactant protein A by dexamethasone metabolites [J]. Am J Physiol Endocrinol Metab. 2006;290(4):E653-660.
[126]. Stewart PM, Rogerson FM, Mason JI. Type 2 11 beta-hydroxysteroid dehydrogenase messenger ribonucleic acid and activity in human placenta and fetal membranes:its relationship to birth weight and putative role in fetal adrenal steroidogenesis [J]. J Clin Endocrinol Metab.1995;80(3):885-890.
[127]. Murphy BE. Cortisol production and inactivation by the human lung during gestation and infancy [J]. J Clin Endocrinol Metab.1978;47(2):243-248.
[128]. Yang Z, Zhu P, Guo C, Zhu X, Sun K. Expression of 11 beta-hydroxysteroid dehydrogenase type 1 in human fetal lung and regulation of its expression by interleukin-1beta and cortisol [J]. J Clin Endocrinol Metab. 2009;94(1):306-313.
[129]. Cole TJ. Cloning of the mouse 11 beta-hydroxysteroid dehydrogenase type 2 gene:tissue specific expression and localization in distal convoluted tubules and collecting ducts of the kidney [J]. Endocrinology. 1995;136(10):4693-4696.
[130]. Brown RW, Diaz R, Robson AC, Kotelevtsev YV, Mullins JJ, Kaufman MH, Seckl JR. The ontogeny of 11 beta-hydroxysteroid dehydrogenase type 2 and mineralocorticoid receptor gene expression reveal intricate control of glucocorticoid action in development [J]. Endocrinology. 1996;137(2):794-797.
[131]. Abramovitz M, Carriero R, Murphy BE. Investigation of factors influencing 11 beta-hydroxysteroid dehydrogenase (EC 1.1.1.146) activity in midgestational human fetal lung monolayer and explant cultures [J]. J Steroid Biochem.1984;21(6):677-683.
[132]. Murphy BE. Ontogeny of cortisol-cortisone interconversion in human tissues: a role for cortisone in human fetal development [J]. J Steroid Biochem. 1981;14(9):811-817.
[133]. Alberts P, Nilsson C, Selen G, Engblom LO, Edling NH, Norling S, Klingstrom G, Larsson C, Forsgren M, Ashkzari M, Nilsson CE, Fiedler M, Bergqvist E, Ohman B, Bjorkstrand E, Abrahmsen LB. Selective inhibition of 11 beta-hydroxysteroid dehydrogenase type 1 improves hepatic insulin sensitivity in hyperglycemic mice strains [J]. Endocrinology. 2003;144(11):4755-4762.
[134]. Wang GM, Ge RS, Latif SA, Morris DJ, Hardy MP. Expression of 11 beta-hydroxylase in rat Leydig cells [J]. Endocrinology. 2002;143(2):621-626.
[135]. Suzuki S, Tsubochi H, Darnel A, Suzuki T, Sasano H, Krozowski ZS, Kondo T. Expression of 11 beta-hydroxysteroid dehydrogenase type 1 in alveolar epithelial cells in rats [J]. Endocr J.2003;50(4):445-451.
[136]. Swaab DF, Visser M, Tilders FJ. Stimulation of intra-uterine growth in rat by alpha-melanocyte-stimulating hormone [J]. J Endocrinol.1976;70(3):445-455.
[137]. Deayton JM, Young IR, Hollingworth SA, White A, Crosby SR, Thorburn GD. Effect of late hypothalamo-pituitary disconnection on the development of the HPA axis in the ovine fetus and the initiation of parturition [J]. J Neuroendocrinol.1994;6(1):25-31.
[138]. Ohrlander S, Gennser G, Eneroth P. Plasma cortisol levels in human fetus during parturition [J]. Obstet Gynecol.1976;48(4):381-387.
[139]. Whittle WL, Patel FA, Alfaidy N, Holloway AC, Fraser M, Gyomorey S, Lye SJ, Gibb W, Challis JR. Glucocorticoid regulation of human and ovine parturition:the relationship between fetal hypothalamic-pituitary-adrenal axis activation and intrauterine prostaglandin production [J]. Biol Reprod. 2001;64(4):1019-1032.
[140]. Goldkrand JW, Schulte RL, Messer RH. Maternal and fetal plasma cortisol levels at parturition [J]. Obstet Gynecol.1976;47(1):41-45.
[141]. Albrecht ED, Pepe GJ. Placental steroid hormone biosynthesis in primate pregnancy [J]. Endocr Rev.1990;11(1):124-150.
[142]. Pepe GJ, Albrecht ED. Regulation of the primate fetal adrenal cortex [J]. Endocr Rev.1990;11(1):151-176.
[143]. Granberg JP, Ballard PL. The role of sulfhydryl groups in the binding of glucocorticoids by cytoplasmic receptors of lung and other mammalian tissues [J]. Endocrinology.1977; 100(4):1160-1168.
[144]. Ballard PL, Ballard RA. Cytoplasmic receptor for glucocorticoids in lung of the human fetus and neonate [J]. J Clin Invest.1974;53(2):477-486.
[145]. Seckl JR.11 beta-hydroxysteroid dehydrogenase isoforms and their implications for blood pressure regulation [J]. Eur J Clin Invest. 1993;23(10):589-601.
[146]. Murphy BE. Chorionic membrane as an extra-adrenal source of foetal cortisol in human amniotic fluid [J]. Nature.1977;266(5598):179-181.
[147]. Li W, Gao L, Wang Y, Duan T, Myatt L, Sun K. Enhancement of cortisol-induced 11 beta-hydroxysteroid dehydrogenase type 1 expression by interleukin lbeta in cultured human chorionic trophoblast cells [J]. Endocrinology.2006;147(5):2490-2495.
[148]. Napolitano A, Voice MW, Edwards CR, Seckl JR, Chapman KE. 11 Beta-hydroxysteroid dehydrogenase 1 in adipocytes:expression is differentiation-dependent and hormonally regulated [J]. J Steroid Biochem Mol Biol.1998;64(5-6):251-260.
[149]. Tomlinson JW, Moore J, Cooper MS, Bujalska I, Shahmanesh M, Burt C, Strain A, Hewison M, Stewart PM. Regulation of expression of 11 beta-hydroxysteroid dehydrogenase type 1 in adipose tissue:tissue-specific induction by cytokines [J]. Endocrinology.2001;142(5):1982-1989.
[150]. Cai TQ, Wong B, Mundt SS, Thieringer R, Wright SD, Hermanowski-Vosatka A. Induction of 11 beta-hydroxysteroid dehydrogenase type 1 but not-2 in human aortic smooth muscle cells by inflammatory stimuli [J]. J Steroid Biochem Mol Biol.2001;77(2-3):117-122.
[151]. Whorwood CB, Donovan SJ, Flanagan D, Phillips DI, Byrne CD. Increased glucocorticoid receptor expression in human skeletal muscle cells may contribute to the pathogenesis of the metabolic syndrome [J]. Diabetes. 2002;51(4):1066-1075.
[152]. Wang Z, Tai HH. Interleukin-1 beta and dexamethasone regulate gene expression of prostaglandin H synthase-2 via the NF-kB pathway in human amnion derived WISH cells [J]. Prostaglandins Leukot Essent Fatty Acids. 1998;59(1):63-69.
[153]. Pryhuber GS, Khalak R, Zhao Q. Regulation of surfactant proteins A and B by TNF-alpha and phorbol ester independent of NF-kappa B [J]. Am J Physiol. 1998;274(2Pt1):L289-295.
[154]. Wissink S, van Heerde EC, vand der Burg B, van der Saag PT. A dual mechanism mediates repression of NF-kappaB activity by glucocorticoids [J]. Mol Endocrinol.1998;12(3):355-363.
[155]. McKay LI, Cidlowski JA. Cross-talk between nuclear factor-kappa B and the steroid hormone receptors:mechanisms of mutual antagonism [J]. Mol Endocrinol.1998;12(1):45-56.
[156]. Gunn L, Hardiman P, Tharmaratnam S, Lowe D, Chard T. Measurement of interleukin-1 alpha and interleukin-6 in pregnancy-associated tissues [J]. Reprod Fertil Dev.1996;8(7):1069-1073.
[157]. Romero R, Parvizi ST, Oyarzun E, Mazor M, Wu YK, Avila C, Athanassiadis AP, Mitchell MD. Amniotic fluid interleukin-1 in spontaneous labor at term [J]. J Reprod Med.1990;35(3):235-238.
[158]. Opsjln SL, Wathen NC, Tingulstad S, Wiedswang G, Sundan A, Waage A, Austgulen R. Tumor necrosis factor, interleukin-1, and interleukin-6 in normal human pregnancy [J]. Am J Obstet Gynecol.1993;169(2 Pt 1):397-404.
[159]. Olah KS, Vince GS, Neilson JP, Deniz G, Johnson PM. Interleukin-6, interferon-gamma, interleukin-8, and granulocyte-macrophage colony stimulating factor levels in human amniotic fluid at term [J]. J Reprod Immunol.1996;32(1):89-98.
[160]. Laham N, Brennecke SP, Bendtzen K, Rice GE. Differential release of interleukin-6 from human gestational tissues in association with labour and in vitro endotoxin treatment [J]. J Endocrinol.1996;149(3):431-439.
[161]. Saito S, Kasahara T, Kato Y, Ishihara Y, Ichijo M. Elevation of amniotic fluid interleukin 6 (IL-6), IL-8 and granulocyte colony stimulating factor (G-CSF) in term and preterm parturition [J]. Cytokine.1993;5(1):81-88.
[162]. Santhanam U, Avila C, Romero R, Viguet H, Ida N, Sakurai S, Sehgal PB. Cytokines in normal and abnormal parturition:elevated amniotic fluid interleukin-6 levels in women with premature rupture of membranes associated with intrauterine infection [J]. Cytokine.1991;3(2):155-163.
[163]. Romero R, Mazor M, Sepulveda W, Avila C, Copeland D, Williams J. Tumor necrosis factor in preterm and term labor [J]. Am J Obstet Gynecol. 1992;166(5):1576-1587.
[164]. Wang EE, Ohlsson A, Kellner JD. Association of Ureaplasma urealyticum colonization with chronic lung disease of prematurity:results of a metaanalysis [J]. J Pediatr.1995;127(4):640-644.
[165]. Yoon BH, Romero R, Park JS, Chang JW, Kim YA, Kim JC, Kim KS. Microbial invasion of the amniotic cavity with Ureaplasma urealyticum is associated with a robust host response in fetal, amniotic, and maternal compartments [J]. Am J Obstet Gynecol.1998;179(5):1254-1260.
[166]. Sun K, Yang K, Challis JR. Differential expression of 11 beta-hydroxysteroid dehydrogenase types 1 and 2 in human placenta and fetal membranes [J]. J Clin Endocrinol Metab.1997;82(1):300-305.
[167]. Kiaei M, Kipiani K, Petri S, Choi DK, Chen J, Calingasan NY, Beal MF. Integrative role of cPLA with COX-2 and the effect of non-steriodal anti-inflammatory drugs in a transgenic mouse model of amyotrophic lateral sclerosis [J]. J Neurochem.2005;93(2):403-411.
[168]. Porreca E, Reale M, Di Febbo C, Di Gioacchino M, Barbacane RC, Castellani ML, Baccante G, Conti P, Cuccurullo F. Down-regulation of cyclooxygenase-2 (COX-2) by interleukin-1 receptor antagonist in human monocytes [J]. Immunology.1996;89(3):424-429.
[169]. Samad TA, Moore KA, Sapirstein A, Billet S, Allchorne A, Poole S, Bonventre JV, Woolf CJ. Interleukin-1beta-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity [J]. Nature. 2001;410(6827):471-475.
[170]. Dieter P, Scheibe R, Kamionka S, Kolada A. LPS-induced synthesis and release of PGE2 in liver macrophages:regulation by CPLA2, COX-1, COX-2, and PGE2 synthase [J]. Adv Exp Med Biol.2002;507:457-462.
[171]. Lin CC, Lin WN, Wang WJ, Sun CC, Tung WH, Wang HH, Yang CM. Functional coupling expression of COX-2 and cPLA2 induced by ATP in rat vascular smooth muscle cells:role of ERK1/2, p38 MAPK, and NF-kappaB [J]. Cardiovasc Res.2009;82(3):522-531.
[172]. Hammami MM, Siiteri PK. Regulation of 11 beta-hydroxysteroid dehydrogenase activity in human skin fibroblasts:enzymatic modulation of glucocorticoid action [J]. J Clin Endocrinol Metab.1991;73(2):326-334.
[173]. Bujalska I, Shimojo M, Howie A, Stewart PM. Human 11 beta-hydroxysteroid dehydrogenase:studies on the stably transfected isoforms and localization of the type 2 isozyme within renal tissue [J]. Steroids.1997;62(1):77-82.
[174]. Blankstein J, Fujieda K, Reyes FI, Faiman C, Winter JS. Cortisol, 11-desoxycortisol, and 21-desoxycortisol concentrations in amniotic fluid during normal pregnancy [J]. Am J Obstet Gynecol.1980;137(7):781-784.
[175]. Muglia LJ, Katz M. The enigma of spontaneous preterm birth [J]. N Engl J Med.362(6):529-535.
[176]. Yoon BH, Romero R, Jun JK, Park KH, Park JD, Ghezzi F, Kim BI. Amniotic fluid cytokines (interleukin-6, tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8) and the risk for the development of bronchopulmonary dysplasia [J]. Am J Obstet Gynecol.1997;177(4):825-830.
[177]. Yoon BH, Romero R, Kim KS, Park JS, Ki SH, Kim BI, Jun JK. A systemic fetal inflammatory response and the development of bronchopulmonary dysplasia [J]. Am J Obstet Gynecol.1999;181(4):773-779.
[178]. Jobe AH, Newnham JP, Willet KE, Moss TJ, Gore Ervin M, Padbury JF, Sly P, Ikegami M. Endotoxin-induced lung maturation in preterm lambs is not mediated by cortisol [J]. Am J Respir Crit Care Med.2000; 162(5):1656-1661.
[179]. Speer CP. Inflammation and bronchopulmonary dysplasia [J]. Semin Neonatol. 2003;8(1):29-38.
[180]. Watterberg KL, Demers LM, Scott SM, Murphy S. Chorioamnionitis and early lung inflammation in infants in whom bronchopulmonary dysplasia develops [J]. Pediatrics.1996;97(2):210-215.
[181]. Hannaford K, Todd DA, Jeffery H, John E, Blyth K, Gilbert GL. Role of ureaplasma urealyticum in lung disease of prematurity [J]. Arch Dis Child Fetal Neonatal Ed.1999;81(3):F162-167.
[182]. Yoon BH, Jun JK, Romero R, Park KH, Gomez R, Choi JH, Kim IO. Amniotic fluid inflammatory cytokines (interleukin-6, interleukin-lbeta, and tumor necrosis factor-alpha), neonatal brain white matter lesions, and cerebral palsy [J]. Am J Obstet Gynecol.1997;177(1):19-26.
[183]. Duncan JR, Cock ML, Scheerlinck JP, Westcott KT, McLean C, Harding R, Rees SM. White matter injury after repeated endotoxin exposure in the preterm ovine fetus [J]. Pediatr Res.2002;52(6):941-949.
[184]. Watterberg KL, Scott SM, Naeye RL. Chorioamnionitis, cortisol, and acute lung disease in very low birth weight infants [J]. Pediatrics.1997;99(2):E6.
[185]. Seckl JR. 11beta-hydroxysteroid dehydrogenases:changing glucocorticoid action [J]. Curr Opin Pharmacol.2004;4(6):597-602.
[186]. Yong PY, Harlow C, Thong KJ, Hillier SG. Regulation of 11beta-hydroxy steroid dehydrogenase type 1 gene expression in human ovarian surface epithelial cells by interleukin-1 [J]. Hum Reprod. 2002;17(9):2300-2306.
[187]. Hardy RS, Filer A, Cooper MS, Parsonage G, Raza K, Hardie DL, Rabbitt EH, Stewart PM, Buckley CD, Hewison M. Differential expression, function and response to inflammatory stimuli of 11 beta-hydroxysteroid dehydrogenase type 1 in human fibroblasts:a mechanism for tissue-specific regulation of inflammation [J]. Arthritis Res Ther.2006;8(4):R108.
[188]. Hardy R, Rabbitt EH, Filer A, Emery P, Hewison M, Stewart PM, Gittoes NJ, Buckley CD, Raza K, Cooper MS. Local and systemic glucocorticoid metabolism in inflammatory arthritis [J]. Ann Rheum Dis. 2008;67(9):1204-1210.
[189]. Arai N, Masuzaki H, Tanaka T, Ishii T, Yasue S, Kobayashi N, Tomita T, Noguchi M, Kusakabe T, Fujikura J, Ebihara K, Hirata M, Hosoda K, Hayashi T, Sawai H, Minokoshi Y, Nakao K. Ceramide and adenosine 5'-monophosphate-activated protein kinase are two novel regulators of 11beta-hydroxysteroid dehydrogenase type 1 expression and activity in cultured preadipocytes [J]. Endocrinology.2007;148(11):5268-5277.
[190]. Cooper MS, Bujalska I, Rabbitt E, Walker EA, Bland R, Sheppard MC, Hewison M, Stewart PM. Modulation of 11 beta-hydroxysteroid dehydrogenase isozymes by proinflammatory cytokines in osteoblasts:an autocrine switch from glucocorticoid inactivation to activation [J]. J Bone Miner Res.2001;16(6):1037-1044.
[191]. Gilmour JS, Coutinho AE, Cailhier JF, Man TY, Clay M, Thomas G, Harris HJ, Mullins JJ, Seckl JR, Savill JS, Chapman KE. Local amplification of glucocorticoids by 11 beta-hydroxysteroid dehydrogenase type 1 promotes macrophage phagocytosis of apoptotic leukocytes [J]. J Immunol. 2006;176(12):7605-7611.
[192]. Greenman IC, Gomez E, Moore CE, Herbert TP. Distinct glucose-dependent stress responses revealed by translational profiling in pancreatic beta-cells [J]. J Endocrinol.2007; 192(1):179-187.
[193]. Anderson P, Phillips K, Stoecklin G, Kedersha N. Post-transcriptional regulation of proinflammatory proteins [J]. J Leukoc Biol.2004;76(1):42-47.
[194]. Blackshear PJ. Tristetraprolin and other CCCH tandem zinc-finger proteins in the regulation of mRNA turnover [J]. Biochem Soc Trans.2002;30(Pt 6):945-952.
[195]. Brivanlou AH, Darnell JE, Jr. Signal transduction and the control of gene expression [J]. Science.2002;295(5556):813-818.
[196]. Korhonen R, Lahti A, Hamalainen M, Kankaanranta H, Moilanen E. Dexamethasone inhibits inducible nitric-oxide synthase expression and nitric oxide production by destabilizing mRNA in lipopolysaccharide-treated macrophages [J]. Mol Pharmacol.2002;62(3):698-704.
[197]. Ozaki T, Habara K, Matsui K, Kaibori M, Kwon AH, Ito S, Nishizawa M, Okumura T. Dexamethasone inhibits the induction of iNOS gene expression through destabilization of its mRNA in proinflammatory cytokine-stimulated hepatocytes [J]. Shock.33(1):64-69.
[198]. Francke U, Foellmer BE. The glucocorticoid receptor gene is in 5q31-q32 [corrected] [J]. Genomics.1989;4(4):610-612.
[199]. Oakley RH, Sar M, Cidlowski JA. The human glucocorticoid receptor beta isoform. Expression, biochemical properties, and putative function [J]. J Biol Chem.1996;271(16):9550-9559.
[200]. Sanchez ER, Toft DO, Schlesinger MJ, Pratt WB. Evidence that the 90-kDa phosphoprotein associated with the untransformed L-cell glucocorticoid receptor is a murine heat shock protein [J]. J Biol Chem. 1985;260(23):12398-12401.
[201]. Beato M, Arnemann J, Chalepakis G, Slater E, Willmann T. Gene regulation by steroid hormones [J]. J Steroid Biochem.1987;27(1-3):9-14.
[202]. Williams LJ, Lyons V, MacLeod I, Rajan V, Darlington GJ, Poli V, Seckl JR, Chapman KE. C/EBP regulates hepatic transcription of 11 beta-hydroxysteroid dehydrogenase type 1. A novel mechanism for cross-talk between the C/EBP and glucocorticoid signaling pathways [J]. J Biol Chem. 2000;275(39):30232-30239.
[203]. Gout J, Tirard J, Thevenon C, Riou JP, Begeot M, Naville D. CCAAT/enhancer-biinding proteins (C/EBPs) regulate the basal and cAMP-induced transcription of the human llbeta-hydroxy steroid dehydrogenase encoding gene in adipose cells [J]. Biochimie. 2006;88(9):1115-1124.
[204]. Baumann H, Jahreis GP, Morella KK, Won KA, Pruitt SC, Jones VE, Prowse KR. Transcriptional regulation through cytokine and glucocorticoid response elements of rat acute phase plasma protein genes by C/EBP and JunB [J]. J Biol Chem.1991;266(30):20390-20399.
[205]. Alam T, An MR, Papaconstantinou J. Differential expression of three C/EBP isoforms in multiple tissues during the acute phase response [J]. J Biol Chem. 1992;267(8):5021-5024.
[206]. Birkenmeier EH, Gwynn B, Howard S, Jerry J, Gordon JI, Landschulz WH, McKnight SL. Tissue-specific expression, developmental regulation, and genetic mapping of the gene encoding CCAAT/enhancer binding protein [J]. Genes Dev.1989;3(8):1146-1156.
[207]. Li F, Rosenberg E, Smith CI, Notarfrancesco K, Reisher SR, Shuman H, Feinstein SI. Correlation of expression of transcription factor C/EBP alpha and surfactant protein genes in lung cells [J]. Am J Physiol.1995;269(2 Pt 1):L241-247.
[208]. Cassel TN, Nord M. C/EBP transcription factors in the lung epithelium [J]. Am J Physiol Lung Cell Mol Physiol.2003;285(4):L773-781.
[209]. Martis PC, Whitsett JA, Xu Y, Perl AK, Wan H, Ikegami M. C/EBPalpha is required for lung maturation at birth [J]. Development. 2006;133(6):1155-1164.
[210]. Flodby P, Barlow C, Kylefjord H, Ahrlund-Richter L, Xanthopoulos KG. Increased hepatic cell proliferation and lung abnormalities in mice deficient in CCAAT/enhancer binding protein alpha [J]. J Biol Chem. 1996;271(40):24753-24760.
[211]. Wang ND, Finegold MJ, Bradley A, Ou CN, Abdelsayed SV, Wilde MD, Taylor LR, Wilson DR, Darlington GJ. Impaired energy homeostasis in C/EBP alpha knockout mice [J]. Science.1995;269(5227):1108-1112.
[212]. Tanaka T, Yoshida N, Kishimoto T, Akira S. Defective adipocyte differentiation in mice lacking the C/EBPbeta and/or C/EBPdelta gene [J]. EMBO J.1997;16(24):7432-7443.
[213]. Rishi V, Gal J, Krylov D, Fridriksson J, Boysen MS, Mandrup S, Vinson C. SREBP-1 dimerization specificity maps to both the helix-loop-helix and leucine zipper domains:use of a dominant negative [J]. J Biol Chem. 2004;279(12):11863-11874.
[214]. Olive M, Williams SC, Dezan C, Johnson PF, Vinson C. Design of a C/EBP-specific, dominant-negative bZIP protein with both inhibitory and gain-of-function properties [J]. J Biol Chem.1996;271(4):2040-2047.
[215]. Chapman KE, Coutinho A, Gray M, Gilmour JS, Savill JS, Seckl JR. Local amplification of glucocorticoids by 11 beta-hydroxysteroid dehydrogenase type 1 and its role in the inflammatory response [J]. Ann N Y Acad Sci. 2006;1088:265-273.
[216]. Stimson RH, Walker BR. Glucocorticoids and 11 beta-hydroxysteroid dehydrogenase type 1 in obesity and the metabolic syndrome [J]. Minerva Endocrinol.2007;32(3):141-159.
[217]. Hecker M, Preiss C, Schini-Kerth VB. Induction by staurosporine of nitric oxide synthase expression in vascular smooth muscle cells:role of NF-kappa B, CREB and C/EBP beta [J]. Br J Pharmacol.1997; 120(6):1067-1074.
[218]. Fukuoka T, Kitami Y, Okura T, Hiwada K. Transcriptional regulation of the platelet-derived growth factor alpha receptor gene via CCAAT/enhancer-binding protein-delta in vascular smooth muscle cells [J]. J Biol Chem.1999;274(36):25576-25582.
[219]. Bujalska IJ, Kumar S, Stewart PM. Does central obesity reflect "Cushing's disease of the omentum"? [J]. Lancet.1997;349(9060):1210-1213.
[220]. Masuzaki H, Paterson J, Shinyama H, Morton NM, Mullins JJ, Seckl JR, Flier JS. A transgenic model of visceral obesity and the metabolic syndrome [J]. Science.2001;294(5549):2166-2170.
[221]. Sai S, Esteves CL, Kelly V, Michailidou Z, Anderson K, Coll AP, Nakagawa Y, Ohzeki T, Seckl JR, Chapman KE. Glucocorticoid regulation of the promoter of 11beta-hydroxysteroid dehydrogenase type 1 is indirect and requires CCAAT/enhancer-binding protein-beta [J]. Mol Endocrinol. 2008;22(9):2049-2060.
[222]. Bruley C, Lyons V, Worsley AG, Wilde MD, Darlington GD, Morton NM, Seckl JR, Chapman KE. A novel promoter for the llbeta-hydroxysteroid dehydrogenase type 1 gene is active in lung and is C/EBPalpha independent [J]. Endocrinology.2006;147(6):2879-2885.
[223]. Chapman KE, Coutinho AE, Gray M, Gilmour JS, Savill JS, Seckl JR. The role and regulation of 11beta-hydroxysteroid dehydrogenase type 1 in the inflammatory response [J]. Mol Cell Endocrinol.2009;301(1-2):123-131.
[224]. Yang Z, Zhu X, Guo C, Sun K. Stimulation of llbeta-HSD1 expression by IL-lbeta via a C/EBP binding site in human fetal lung fibroblasts [J]. Endocrine.2009.
[225]. Ignatova ID, Kostadinova RM, Goldring CE, Nawrocki AR, Frey FJ, Frey BM. Tumor necrosis factor-alpha upregulates 11beta-hydroxysteroid dehydrogenase type 1 expression by CCAAT/enhancer binding protein-beta in HepG2 cells [J]. Am J Physiol Endocrinol Metab.2009;296(2):E367-377.
[226]. Tsugita M, Iwasaki Y, Nishiyama M, Taguchi T, Shinahara M, Taniguchi Y, Kambayashi M, Terada Y, Hashimoto K. Differential regulation of 11beta-hydroxysteroid dehydrogenase type-1 and-2 gene transcription by proinflammatory cytokines in vascular smooth muscle cells [J]. Life Sci. 2008;83(11-12):426-432.
[227]. Iwasaki Y, Takayasu S, Nishiyama M, Tsugita M, Taguchi T, Asai M, Yoshida M, Kambayashi M, Hashimoto K. Is the metabolic syndrome an intracellular Cushing state? Effects of multiple humoral factors on the transcriptional activity of the hepatic glucocorticoid-activating enzyme (11 beta-hydroxysteroid dehydrogenase type 1) gene [J]. Mol Cell Endocrinol. 2008;285(1-2):10-18.
[228]. Basseres DS, Levantini E, Ji H, Monti S, Elf S, Dayaram T, Fenyus M, Kocher O, Golub T, Wong KK, Halmos B, Tenen DG. Respiratory failure due to differentiation arrest and expansion of alveolar cells following lung-specific loss of the transcription factor C/EBPalpha in mice [J]. Mol Cell Biol. 2006;26(3):1109-1123.
[229]. Rosenberg E, Li F, Reisher SR, Wang M, Gonzales LW, Ewing JR, Malek S, Ballard PL, Notarfrancesco K, Shuman H, Feinstein SI. Members of the C/EBP transcription factor family stimulate expression of the human and rat surfactant protein A (SP-A) genes [J]. Biochim Biophys Acta. 2002;1575(1-3):82-90.
[230]. Seidner S, Pettenazzo A, Ikegami M, Jobe A. Corticosteroid potentiation of surfactant dose response in preterm rabbits [J]. J Appl Physiol. 1988;64(6):2366-2371.
[231]. Johnson JW, Mitzner W, London WT, Palmer AE, Scott R, Kearney K. Glucocorticoids and the rhesus fetal lung [J]. Am J Obstet Gynecol. 1978; 130(8):905-916.
[232]. Platzker AC, Kitterman JA, Mescher EJ, Clements JA, Tooley WH. Surfactant in the lung and tracheal fluid of the fetal lamb and acceleration of its appearance by dexamethasone [J]. Pediatrics.1975;56(4):554-561.
[233]. Rooney SA, Young SL, Mendelson CR. Molecular and cellular processing of lung surfactant [J]. FASEB J.1994;8(12):957-967.
[234]. Gonzales LW, Ertsey R, Ballard PL, Froh D, Goerke J, Gonzales J. Glucocorticoid stimulation of fatty acid synthesis in explants of human fetal lung [J]. Biochim Biophys Acta.1990;1042(1):1-12.
[235]. Wagle S, Bui A, Ballard PL, Shuman H, Gonzales J, Gonzales LW. Hormonal regulation and cellular localization of fatty acid synthase in human fetal lung [J]. Am J Physiol.1999;277(2 Pt 1):L381-390.
[236]. Hillgartner FB, Salati LM, Goodridge AG. Physiological and molecular mechanisms involved in nutritional regulation of fatty acid synthesis [J]. Physiol Rev.1995;75(1):47-76.
[237]. Smith S. The animal fatty acid synthase:one gene, one polypeptide, seven enzymes [J]. FASEB J.1994;8(15):1248-1259.
[238]. Wakil SJ, Stoops JK, Joshi VC. Fatty acid synthesis and its regulation [J]. Annu Rev Biochem.1983;52:537-579.
[239]. Pope TS, Smart DA, Rooney SA. Hormonal effects on fatty-acid synthase in cultured fetal rat lung; induction by dexamethasone and inhibition of activity by triiodothyronine [J]. Biochim Biophys Acta.1988;959(2):169-177.
[240]. Boggaram V, Mendelson CR. Transcriptional regulation of the gene encoding the major surfactant protein (SP-A) in rabbit fetal lung [J]. J Biol Chem. 1988;263(35):19060-19065.
[241]. Warr RG, Hawgood S, Buckley DI, Crisp TM, Schilling J, Benson BJ, Ballard PL, Clements JA, White RT. Low molecular weight human pulmonary surfactant protein (SP5):isolation, characterization, and cDNA and amino acid sequences [J]. Proc Natl Acad Sci U S A.1987;84(22):7915-7919.
[242]. Rooney SA, Gobran LI, Chu AJ. Thyroid hormone opposes some glucocorticoid effects on glycogen content and lipid synthesis in developing fetal rat lung [J]. Pediatr Res.1986;20(6):545-550.
[243]. Maniscalco WM, Finkelstein JN, Parkhurst AB. Dexamethasone increases de novo fatty acid synthesis in fetal rabbit lung explants [J]. Pediatr Res. 1985;19(12):1272-1277.
[244]. Xu ZX, Stenzel W, Sasic SM, Smart DA, Rooney SA. Glucocorticoid regulation of fatty acid synthase gene expression in fetal rat lung [J]. Am J Physiol.1993;265(2Pt 1):L140-147.
[245]. Xu ZX, Viviano CJ, Rooney SA. Glucocorticoid stimulation of fatty-acid synthase gene transcription in fetal lung:antagonism by retinoic acid [J]. Am J Physiol.1995;268(4Pt 1):L683-690.
[246]. Xu ZX, Rooney SA. Glucocorticoids increase fatty-acid synthase mRNA stability in fetal rat lung [J]. Am J Physiol.1997;272(5 Pt 1):L860-864.
[247]. Hawgood S, Clements JA. Pulmonary surfactant and its apoproteins [J]. J Clin Invest.1990;86(1):1-6.
[248]. Weaver TE, Whitsett JA. Function and regulation of expression of pulmonary surfactant-associated proteins [J]. Biochem J.1991;273(Pt 2):249-264.
[249]. Clark JC, Weaver TE, Iwamoto HS, Ikegami M, Jobe AH, Hull WM, Whitsett JA. Decreased lung compliance and air trapping in heterozygous SP-B-deficient mice [J]. Am J Respir Cell Mol Biol.1997;16(1):46-52.
[250]. Ballard PL, Hawgood S, Liley H, Wellenstein G, Gonzales LW, Benson B, Cordell B, White RT. Regulation of pulmonary surfactant apoprotein SP 28-36 gene in fetal human lung [J]. Proc Natl Acad Sci U S A. 1986;83(24):9527-9531.
[251]. Liley HG, Hawgood S, Wellenstein GA, Benson B, White RT, Ballard PL. Surfactant protein of molecular weight 28,000-36,000 in cultured human fetal lung:cellular localization and effect of dexamethasone [J]. Mol Endocrinol. 1987;1(3):205-215.
[252]. O'Reilly MA, Gazdar AF, Clark JC, Pilot-Matias TJ, Wert SE, Hull WM, Whitsett JA. Glucocorticoids regulate surfactant protein synthesis in a pulmonary adenocarcinoma cell line [J]. Am J Physiol.1989;257(6 Pt 1):L385-392.
[253]. Boggaram V, Smith ME, Mendelson CR. Posttranscriptional regulation of surfactant protein-A messenger RNA in human fetal lung in vitro by glucocorticoids [J]. Mol Endocrinol.1991;5(3):414-423.
[254]. Nichols KV, Floros J, Dynia DW, Veletza SV, Wilson CM, Gross I. Regulation of surfactant protein A mRNA by hormones and butyrate in cultured fetal rat lung [J]. Am J Physiol.1990;259(6 Pt 1):L488-495.
[255]. Schellhase DE, Shannon JM. Effects of maternal dexamethasone on expression of SP-A, SP-B, and SP-C in the fetal rat lung [J]. Am J Respir Cell Mol Biol.1991;4(4):304-312.
[256]. Phelps DS, Floros J. Dexamethasone in vivo raises surfactant protein B mRNA in alveolar and bronchiolar epithelium [J]. Am J Physiol.1991;260(2 Pt1):L146-152.
[257]. Connelly IH, Hammond GL, Harding PG, Possmayer F. Levels of surfactant-associated protein messenger ribonucleic acids in rabbit lung during perinatal development and after hormonal treatment [J]. Endocrinology. 1991;129(5):2583-2591.
[258]. Boggaram V, Smith ME, Mendelson CR. Regulation of expression of the gene encoding the major surfactant protein (SP-A) in human fetal lung in vitro. Disparate effects of glucocorticoids on transcription and on mRNA stability [J]. J Biol Chem.1989;264(19):11421-11427.
[259]. George TN, Miakotina OL, Goss KL, Snyder JM. Mechanism of all trans-retinoic acid and glucocorticoid regulation of surfactant protein mRNA [J]. Am J Physiol.1998;274(4Pt 1):L560-566.
[260]. Alcorn JL, Gao E, Chen Q, Smith ME, Gerard RD, Mendelson CR. Genomic elements involved in transcriptional regulation of the rabbit surfactant protein-A gene [J]. Mol Endocrinol.1993;7(8):1072-1085.
[261]. Smith CI, Rosenberg E, Reisher SR, Li F, Kefalides P, Fisher AB, Feinstein SI. Sequence of rat surfactant protein A gene and functional mapping of its upstream region [J]. Am J Physiol.1995;269(5 Pt 1):L603-612.
[262]. Kouretas D, Karinch AM, Rishi A, Melchers K, Floros J. Conservation analysis of rat and human SP-A gene identifies 5'flanking sequences of rat SP-A that bind rat lung nuclear proteins [J]. Exp Lung Res. 1993;19(4):485-503.
[263]. Young SL, Fram EK, Spain CL, Larson EW. Development of type II pneumocytes in rat lung [J].Am J Physiol.1991;260(2 Pt 1):L113-122.
[264]. Shimizu H, Miyamura K, Kuroki Y. Appearance of surfactant proteins, SP-A and SP-B, in developing rat lung and the effects of in vivo dexamethasone treatment [J]. Biochim Biophys Acta.1991; 1081 (1):53-60.
[265]. Liley HG, White RT, Warr RG, Benson BJ, Hawgood S, Ballard PL. Regulation of messenger RNAs for the hydrophobic surfactant proteins in human lung [J]. J Clin Invest.1989;83(4):1191-1197.
[266]. Weaver TE, Sarin VK, Sawtell N, Hull WM, Whitsett JA. Identification of surfactant proteolipid SP-B in human surfactant and fetal lung [J]. J Appl Physiol.1988;65(2):982-987.
[267]. O'Reilly MA, Gazdar AF, Morris RE, Whitsett JA. Differential effects of glucocorticoid on expression of surfactant proteins in a human lung adenocarcinoma cell line [J]. Biochim Biophys Acta.1988;970(2):194-204.
[268]. O'Reilly MA, Clark JC, Whitsett JA. Glucocorticoid enhances pulmonary surfactant protein B gene transcription [J]. Am J Physiol.1991;260(2 Pt 1):L37-43.
[269]. Margana RK, Boggaram V. Transcription and mRNA stability regulate developmental and hormonal expression of rabbit surfactant protein B gene [J]. Am J Physiol.1995;268(3 Pt 1):L481-490.
[270]. Pilot-Matias TJ, Kister SE, Fox JL, Kropp K, Glasser SW, Whitsett JA. Structure and organization of the gene encoding human pulmonary surfactant proteolipid SP-B [J]. DNA.1989;8(2):75-86.
[271]. Veletza SV, Nichols KV, Gross I, Lu H, Dynia DW, Floros J. Surfactant protein C:hormonal control of SP-C mRNA levels in vitro [J]. Am J Physiol. 1992;262(6Pt1):L684-687.
[272]. Glasser SW, Korfhagen TR, Bruno MD, Dey C, Whitsett JA. Structure and expression of the pulmonary surfactant protein SP-C gene in the mouse [J]. J Biol Chem.1990;265(35):21986-21991.
[273]. Glasser SW, Korfhagen TR, Wert SE, Bruno MD, Mc Williams KM, Vorbroker DK, Whitsett JA. Genetic element from human surfactant protein SP-C gene confers bronchiolar-alveolar cell specificity in transgenic mice [J]. Am J Physiol.1991;261(4Pt 1):L349-356.
[274]. Deterding RR, Shimizu H, Fisher JH, Shannon JM. Regulation of surfactant protein D expression by glucocorticoids in vitro and in vivo [J]. Am J Respir Cell Mol Biol.1994;10(1):30-37.
[275]. Ogasawara Y, Kuroki Y, Shiratori M, Shimizu H, Miyamura K, Akino T. Ontogeny of surfactant apoprotein D, SP-D, in the rat lung [J]. Biochim Biophys Acta.1991;1083(3):252-256.
[276]. Rust K, Bingle L, Mariencheck W, Persson A, Crouch EC. Characterization of the human surfactant protein D promoter:transcriptional regulation of SP-D gene expression by glucocorticoids [J]. Am J Respir Cell Mol Biol. 1996;14(2):121-130.
[277]. Cronstein BN, Kimmel SC, Levin RI, Martiniuk F, Weissmann G. A mechanism for the antiinflammatory effects of corticosteroids:the glucocorticoid receptor regulates leukocyte adhesion to endothelial cells and expression of endothelial-leukocyte adhesion molecule 1 and intercellular adhesion molecule 1 [J]. Proc Natl Acad Sci U S A.1992;89(21):9991-9995.
[278]. Kwon OJ, Jose PJ, Robbins RA, Schall TJ, Williams TJ, Barnes PJ. Glucocorticoid inhibition of RANTES expression in human lung epithelial cells [J]. Am J Respir Cell Mol Biol.1995;12(5):488-496.
[279]. Newton R, Kuitert LM, Slater DM, Adcock IM, Barnes PJ. Cytokine induction of cytosolic phospholipase A2 and cyclooxygenase-2 mRNA is suppressed by glucocorticoids in human epithelial cells [J]. Life Sci.1997;60(1):67-78.
[280]. Nakano T, Arita H. Enhanced expression of group II phospholipase A2 gene in the tissues of endotoxin shock rats and its suppression by glucocorticoid [J]. FEBS Lett.1990;273(1-2):23-26.
[281]. Mitchell JA, Belvisi MG, Akarasereenont P, Robbins RA, Kwon OJ, Croxtall J, Barnes PJ, Vane JR. Induction of cyclo-oxygenase-2 by cytokines in human pulmonary epithelial cells:regulation by dexamethasone [J]. Br J Pharmacol. 1994; 113(3):1008-1014.
[282]. Levine SJ, Benfield T, Shelhamer JH. Corticosteroids induce intracellular interleukin-1 receptor antagonist type I expression by a human airway epithelial cell line [J]. Am J Respir Cell Mol Biol.1996; 15(2):245-251.
[283]. Guy J, Dhanireddy R, Mukherjee AB. Surfactant-producing rabbit pulmonary alveolar type Ⅱ cells synthesize and secrete an antiinflammatory protein, uteroglobin [J]. Biochem Biophys Res Commun.1992;189(2):662-669.
[284]. Torkkeli T, Krusius T, Janne O. Uterine and lung uteroglobins in the rabbit. Two similar proteins with differential hormonal regulation [J]. Biochim Biophys Acta.1978;544(3):578-592.
[285]. Lombardero M, Nieto A. Glucocorticoid and developmental regulation of uteroglobin synthesis in rabbit lung [J]. Biochem J.1981;200(3):487-494.
[286]. Fogari R, Zoppi A, Lusardi P, Marasi G, Villa G, Vanasia A. Cigarette smoking and blood pressure in a worker population:a cross-sectional study [J]. J Cardiovasc Risk.1996;3(1):55-59.
[287]. Ray KP, Farrow S, Daly M, Talabot F, Searle N. Induction of the E-selectin promoter by interleukin 1 and tumour necrosis factor alpha, and inhibition by glucocorticoids [J]. Biochem J.1997;328 (Pt 2):707-715.
[288]. Robbins RA, Springall DR, Warren JB, Kwon OJ, Buttery LD, Wilson AJ, Adcock IM, Riveros-Moreno V, Moncada S, Polak J, et al. Inducible nitric oxide synthase is increased in murine lung epithelial cells by cytokine stimulation [J]. Biochem Biophys Res Commun.1994;198(3):835-843.
[289]. Kleinert H, Euchenhofer C, Ihrig-Biedert I, Forstermann U. Glucocorticoids inhibit the induction of nitric oxide synthase Ⅱ by down-regulating cytokine-induced activity of transcription factor nuclear factor-kappa B [J]. Mol Pharmacol.1996;49(1):15-21.
[290]. Di Rosa M, Radornski M, Carnuccio R, Moncada S. Glucocorticoids inhibit the induction of nitric oxide synthase in macrophages [J]. Biochem Biophys Res Commun.1990;172(3):1246-1252.
[291]. Knowles RG, Salter M, Brooks SL, Moncada S. Anti-inflammatory glucocorticoids inhibit the induction by endotoxin of nitric oxide synthase in the lung, liver and aorta of the rat [J]. Biochem Biophys Res Commun. 1990; 172(3):1042-1048.
[292]. Radomski MW, Palmer RM, Moncada S. Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells [J]. Proc Natl Acad Sci U S A. 1990;87(24):10043-10047.
[293]. Matsuba T, Keicho N, Higashimoto Y, Granleese S, Hogg JC, Hayashi S, Bondy GP. Identification of glucocorticoid-and adenovirus E1A-regulated genes in lung epithelial cells by differential display [J]. Am J Respir Cell Mol Biol.1998;18(2):243-254.
[294]. Friedland J, Setton C, Silverstein E. Angiotensin converting enzyme:induction by steroids in rabbit alveolar macrophages in culture [J]. Science. 1977;197(4298):64-65.
[295]. Mendelsohn FA, Lloyd CJ, Kachel C, Funder JW. Induction by glucocorticoids of angiotensin converting enzyme production from bovine endothelial cells in culture and rat lung in vivo [J]. J Clin Invest. 1982;70(3):684-692.
[296]. Chen ZJ, Parent L, Maniatis T. Site-specific phosphorylation of IkappaBalpha by a novel ubiquitination-dependent protein kinase activity [J]. Cell. 1996;84(6):853-862.
[297]. Liggins GC, Howie RN. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants [J]. Pediatrics.1972;50(4):515-525.
[298]. Banks BA, Cnaan A, Morgan MA, Parer JT, Merrill JD, Ballard PL, Ballard RA. Multiple courses of antenatal corticosteroids and outcome of premature neonates. North American Thyrotropin-Releasing Hormone Study Group [J]. Am J Obstet Gynecol.1999;181(3):709-717.
[299]. Kari MA, Akino T, Hallman M. Prenatal dexamethasone and exogenous surfactant therapy:surface activity and surfactant components in airway specimens [J]. Pediatr Res.1995;38(5):676-684.
[300]. Ballard PL, Ballard RA. Scientific basis and therapeutic regimens for use of antenatal glucocorticoids [J]. Am J Obstet Gynecol.1995; 173(1):254-262.
[301]. Silver RK, Vyskocil C, Solomon SL, Ragin A, Neerhof MG, Farrell EE. Randomized trial of antenatal dexamethasone in surfactant-treated infants delivered before 30 weeks' gestation [J]. Obstet Gynecol.1996;87(5 Pt 1):683-691.
[302]. Harding JE, Pang J, Knight DB, Liggins GC. Do antenatal corticosteroids help in the setting of preterm rupture of membranes? [J]. Am J Obstet Gynecol. 2001; 184(2):131-139.
[303]. Murphy BE. Conjugated glucocorticoids in amniotic fluid and fetal lung maturation [J]. J Clin Endocrinol Metab.1978;47(1):212-215.
[304]. Beers MF, Shuman H, Liley HG, Floros J, Gonzales LW, Yue N, Ballard PL. Surfactant protein B in human fetal lung:developmental and glucocorticoid regulation [J]. Pediatr Res.1995;38(5):668-675.
[305]. Rebello CM, Ikegami M, Polk DH, Jobe AH. Postnatal lung responses and surfactant function after fetal or maternal corticosteroid treatment [J]. J Appl Physiol.1996;80(5):1674-1680.
[306]. Ikegami M, Polk DH, Jobe AH, Newnham J, Sly P, Kohan R, Kelly R. Effect of interval from fetal corticosteriod treatment to delivery on postnatal lung function of preterm lambs [J]. J Appl Physiol.1996;80(2):591-597.
[307]. Jobe AH, Ikegami M. Antenatal infection/inflammation and postnatal lung maturation and injury [J]. Respir Res.2001;2(1):27-32.
[308]. Jobe AH. Glucocorticoids, inflammation and the perinatal lung [J]. Semin Neonatol.2001;6(4):331-342.
[309]. van der Heide-Jalving M, Kamphuis PJ, van der Laan MJ, Bakker JM, Wiegant VM, Heijnen CJ, Veen S, van Bel F. Short-and long-term effects of neonatal glucocorticoid therapy:is hydrocortisone an alternative to dexamethasone? [J]. Acta Paediatr.2003;92(7):827-835.
[310]. Andre P, Thebaud B, Odievre MH, Razafimahefa H, Zupan V, Dehan M, Lacaze-Masmonteil T. Methylprednisolone, an alternative to dexamethasone in very premature infants at risk of chronic lung disease [J]. Intensive Care Med.2000;26(10):1496-1500.
[2]. Young IR, Thorburn GD. Prostaglandin E2, fetal maturation and ovine parturition [J]. Aust N Z J Obstet Gynaecol.1994;34(3):342-346.
[3]. Currie WB, Thorburn GD. The fetal role in timing the initiation of parturition in the goat [J]. Ciba Found Symp.1977(47):49-72.
[4]. Walfisch A, Hallak M, Mazor M. Multiple courses of antenatal steroids:risks and benefits [J]. Obstet Gynecol.2001;98(3):491-497.
[5]. Crowley P. Prophylactic corticosteroids for preterm birth [J]. Cochrane Database Syst Rev.2000(2):CD000065.
[6]. Challis JR, Lye SJ. Parturition [J]. Oxf Rev Reprod Biol.1986;8:61-129.
[7]. Bassett JM, Thorburn GD. Foetal plasma corticosteroids and the initiation of parturition in sheep [J]. J Endocrinol.1969;44(2):285-286.
[8]. Liley HG, Ertsey R, Gonzales LW, Odom MW, Hawgood S, Dobbs LG, Ballard PL. Synthesis of surfactant components by cultured type II cells from human lung [J]. Biochim Biophys Acta.1988;961(1):86-95.
[9]. Maniscalco WM, Shapiro DL. Effects of dexamethasone on beta-adrenergic receptors in fetal lung explants [J]. Pediatr Res.1983;17(4):274-277.
[10]. Liley HG, White RT, Benson BJ, Ballard PL. Glucocorticoids both stimulate and inhibit production of pulmonary surfactant protein A in fetal human lung [J]. Proc Natl Acad Sci U S A.1988;85(23):9096-9100.
[11]. Ballard PL, Ertsey R, Gonzales LW, Gonzales J. Transcriptional regulation of human pulmonary surfactant proteins SP-B and SP-C by glucocorticoids [J]. Am J Respir Cell Mol Biol.1996;14(6):599-607.
[12]. Mariencheck W, Crouch E. Modulation of surfactant protein D expression by glucocorticoids in fetal rat lung [J]. Am J Respir Cell Mol Biol. 1994; 10(4):419-429.
[13]. Dulkerian SJ, Gonzales LW, Ning Y, Ballard PL. Regulation of surfactant protein D in human fetal lung [J]. Am J Respir Cell Mol Biol. 1996; 15(6):781-786.
[14]. Xu J, Possmayer F. Exposure of rabbit fetal lung to glucocorticoids in vitro does not enhance transcription of the gene encoding pulmonary surfactant-associated protein-B (SP-B) [J]. Biochim Biophys Acta. 1993;1169(2):146-155.
[15]. Post M. Maternal administration of dexamethasone stimulates choline-phosphate cytidylyltransferase in fetal type Ⅱ cells [J]. Biochem J. 1987;241(1):291-296.
[16]. Sharma A, Gonzales LW, Ballard PL. Hormonal regulation of cholinephosphate cytidylyltransferase in human fetal lung [J]. Biochim Biophys Acta.1993;1170(3):237-244.
[17]. Rooney SA, Smart DA, Weinhold PA, Feldman DA. Dexamethasone increases the activity but not the amount of choline-phosphate cytidylyltransferase in fetal rat lung [J]. Biochim Biophys Acta.1990;1044(3):385-389.
[18]. Guttentag SH, Beers MF, Bieler BM, Ballard PL. Surfactant protein B processing in human fetal lung [J]. Am J Physiol.1998;275(3 Pt 1):L559-566.
[19]. Solarin KO, Ballard PL, Guttentag SH, Lomax CA, Beers MF. Expression and glucocorticoid regulation of surfactant protein C in human fetal lung [J]. Pediatr Res.1997;42(3):356-364.
[20]. Pierce RA, Mariencheck WI, Sandefur S, Crouch EC, Parks WC. Glucocorticoids upregulate tropoelastin expression during late stages of fetal lung development [J]. Am J Physiol.1995;268(3 Pt 1):L491-500.
[21]. Yee W, Wang J, Liu J, Tseu I, Kuliszewski M, Post M. Glucocorticoid-induced tropoelastin expression is mediated via transforming growth factor-beta 3 [J]. Am J Physiol.1996;270(6Pt 1):L992-1001.
[22]. Schellenberg JC, Liggins GC, Stewart AW. Growth, elastin concentration, and collagen concentration of perinatal rat lung:effects of dexamethasone [J]. Pediatr Res.1987;21(6):603-607.
[23]. Ledo I, Wu M, Katchman S, Brown D, Kennedy S, Hsu-Wong S, Uitto J. Glucocorticosteroids up-regulate human elastin gene promoter activity in transgenic mice [J]. J Invest Dermatol.1994;103(5):632-636.
[24]. Tchepichev S, Ueda J, Canessa C, Rossier BC, O'Brodovich H. Lung epithelial Na channel subunits are differentially regulated during development and by steroids [J]. Am J Physiol.1995;269(3 Pt 1):C805-812.
[25]. Ingbar DH, Duvick S, Savick SK, Schellhase DE, Detterding R, Jamieson JD, Shannon JM. Developmental changes of fetal rat lung Na-K-ATPase after maternal treatment with dexamethasone [J]. Am J Physiol.1997;272(4 Pt 1):L665-672.
[26]. King LS, Nielsen S, Agre P. Aquaporin-1 water channel protein in lung: ontogeny, steroid-induced expression, and distribution in rat [J]. J Clin Invest. 1996;97(10):2183-2191.
[27]. Giannopoulos G, Smith SK. Hormonal regulation of beta-adrenergic receptors in fetal rabbit lung in organ culture [J]. Life Sci.1982;31(8):795-802.
[28]. Cheng JB, Goldfien A, Ballard PL, Roberts JM. Glucocorticoids increase pulmonary beta-adrenergic receptors in fetal rabbit [J]. Endocrinology. 1980; 107(5):1646-1648.
[29]. Barnes P, Jacobs M, Roberts JM. Glucocorticoids preferentially increase fetal alveolar beta-adrenoreceptors:autoradiographic evidence [J]. Pediatr Res. 1984;18(11):1191-1194.
[30]. Frank L, Lewis PL, Sosenko IR. Dexamethasone stimulation of fetal rat lung antioxidant enzyme activity in parallel with surfactant stimulation [J]. Pediatrics.1985;75(3):569-574.
[31]. Randhawa P, Hass M, Frank L, Massaro D. Dexamethasone increases superoxide dismutase activity in serum-free rat fetal lung organ cultures [J]. Pediatr Res.1986;20(9):895-898.
[32]. Clerch LB, Iqbal J, Massaro D. Perinatal rat lung catalase gene expression: influence of corticosteroid and hyperoxia [J]. Am J Physiol.1991;260(6 Pt 1):L428-433.
[33]. Liggins GC. Premature parturition after infusion of corticotrophin or cortisol into foetal lambs [J]. J Endocrinol.1968;42(2):323-329.
[34]. Liggins GC. Premature delivery of foetal lambs infused with glucocorticoids [J]. J Endocrinol.1969;45(4):515-523.
[35]. McLean M, Bisits A, Davies J, Woods R, Lowry P, Smith R. A placental clock controlling the length of human pregnancy [J]. Nat Med.1995;1(5):460-463.
[36]. Sandman CA, Glynn L, Schetter CD, Wadhwa P, Garite T, Chicz-DeMet A, Hobel C. Elevated maternal cortisol early in pregnancy predicts third trimester levels of placental corticotropin releasing hormone (CRH):priming the placental clock [J]. Peptides.2006;27(6):1457-1463.
[37]. Jones SA, Brooks AN, Challis JR. Steroids modulate corticotropin-releasing hormone production in human fetal membranes and placenta [J]. J Clin Endocrinol Metab.1989;68(4):825-830.
[38]. Newman SP, Flower RJ, Croxtall JD. Dexamethasone suppression of 1L-1 beta-induced cyclooxygenase 2 expression is not mediated by lipocortin-1 in A549 cells [J]. Biochem Biophys Res Commun.1994;202(2):931-939.
[39]. DeWitt DL, Meade EA. Serum and glucocorticoid regulation of gene transcription and expression of the prostaglandin H synthase-1 and prostaglandin H synthase-2 isozymes [J]. Arch Biochem Biophys. 1993;306(1):94-102.
[40]. Samet JM, Fasano MB, Fonteh AN, Chilton FH. Selective induction of prostaglandin G/H synthase I by stem cell factor and dexamethasone in mast cells [J]. J Biol Chem.1995;270(14):8044-8049.
[41]. Potestio FA, Zakar T, Olson DM. Glucocorticoids stimulate prostaglandin synthesis in human amnion cells by a receptor-mediated mechanism [J]. J Clin Endocrinol Metab.1988;67(6):1205-1210.
[42]. Patel FA, Clifton VL, Chwalisz K, Challis JR. Steroid regulation of prostaglandin dehydrogenase activity and expression in human term placenta and chorio-decidua in relation to labor [J]. J Clin Endocrinol Metab. 1999;84(1):291-299.
[43]. Sun K, Adamson SL, Yang K, Challis JR. Interconversion of cortisol and cortisone by 11 beta-hydroxysteroid dehydrogenases type 1 and 2 in the perfused human placenta [J]. Placenta.1999;20(1):13-19.
[44]. Sun K, Yang K, Challis JR. Regulation of 11beta-hydroxysteroid dehydrogenase type 2 by progesterone, estrogen, and the cyclic adenosine 5'-monophosphate pathway in cultured human placental and chorionic trophoblasts [J]. Biol Reprod.1998;58(6):1379-1384.
[45]. Condon JC, Jeyasuria P, Faust JM, Mendelson CR. Surfactant protein secreted by the maturing mouse fetal lung acts as a hormone that signals the initiation of parturition [J]. Proc Natl Acad Sci U S A.2004;101(14):4978-4983.
[46]. Ballard PL, Kitterman JA, Bland RD, Clyman RI, Gluckman PD, Platzker AC, Kaplan SL, Grumbach MM. Ontogeny and regulation of corticosteroid binding globulin capacity in plasma of fetal and newborn lambs [J]. Endocrinology.1982;110(2):359-366.
[47]. Fairclough RJ, Liggins GC. Protein binding of plasma cortisol in the foetal lamb near term [J]. J Endocrinol.1975;67(3):333-341.
[48]. Edwards CR, Benediktsson R, Lindsay RS, Seckl JR.11 beta-Hydroxysteroid dehydrogenases:key enzymes in determining tissue-specific glucocorticoid effects [J]. Steroids.1996;61(4):263-269.
[49]. Diederich S, Eigendorff E, Burkhardt P, Quinkler M, Bumke-Vogt C, Rochel M, Seidelmann D, Esperling P, Oelkers W, Bahr V. llbeta-hydroxysteroid dehydrogenase types 1 and 2:an important pharmacokinetic determinant for the activity of synthetic mineralo-and glucocorticoids [J]. J Clin Endocrinol Metab.2002;87(12):5695-5701.
[50]. Draper N, Stewart PM. 11beta-hydroxysteroid dehydrogenase and the pre-receptor regulation of corticosteroid hormone action [J]. J Endocrinol. 2005;186(2):251-271.
[51]. Tomlinson JW, Walker EA, Bujalska IJ, Draper N, Lavery GG, Cooper MS, Hewison M, Stewart PM. llbeta-hydroxysteroid dehydrogenase type 1:a tissue-specific regulator of glucocorticoid response [J]. Endocr Rev. 2004;25(5):831-866.
[52]. Michael AE, Thurston LM, Rae MT. Glucocorticoid metabolism and reproduction:a tale of two enzymes [J]. Reproduction.2003;126(4):425-441.
[53]. Hundertmark S, Dill A, Ebert A, Zimmermann B, Kotelevtsev YV, Mullins JJ, Seckl JR. Foetal lung maturation in 11beta-hydroxysteroid dehydrogenase type 1 knockout mice [J]. Horm Metab Res.2002;34(10):545-549.
[54]. Alfaidy N, Li W, MacIntosh T, Yang K, Challis J. Late gestation increase in 11beta-hydroxysteroid dehydrogenase 1 expression in human fetal membranes: a novel intrauterine source of cortisol [J]. J Clin Endocrinol Metab. 2003;88(10):5033-5038.
[55]. Stewart PM, Murry BA, Mason JI. Type 2 11 beta-hydroxysteroid dehydrogenase in human fetal tissues [J]. J Clin Endocrinol Metab. 1994;78(6):1529-1532.
[56]. Pasqualini JR, Marfil J, Gamier F, Wiqvist N, Diczfalusy E. Studies on the metabolism of corticosteroids in the human foeto-placental unit.4. Metabolism of deoxycorticosterone and corticosterone administered simultaneously into the intact umbilical circulation [J]. Acta Endocrinol (Copenh).1970;64(3):385-397.
[57]. Smith BT, Torday JS, Giroud CJ. The growth promoting effect of cortisol on human fetal lung cells [J]. Steroids.1973;22(4):515-524.
[58]. Tannin GM, Agarwal AK, Monder C, New MI, White PC. The human gene for 11 beta-hydroxysteroid dehydrogenase. Structure, tissue distribution, and chromosomal localization [J]. J Biol Chem.1991;266(25):16653-16658.
[59]. Page N, Warriar N, Govindan MV.11 beta-hydroxysteroid dehydrogenase activity in human lung cells and transcription regulation by glucocorticoids [J]. Am J Physiol.1994;267(4 Pt 1):L464-474.
[60]. Soldan M, Nagel G, Losekam M, Ernst M, Maser E. Interindividual variability in the expression and NNK carbonyl reductase activity of 11 beta-hydroxysteroid dehydrogenase 1 in human lung [J]. Cancer Lett. 1999;145(1-2):49-56.
[61]. Finckh C, Atalla A, Nagel G, Stinner B, Maser E. Expression and NNK reducing activities of carbonyl reductase and 11beta-hydroxysteroid dehydrogenase type 1 in human lung [J]. Chem Biol Interact. 2001;130-132(1-3):761-773.
[62]. Sun K, He P, Yang K. Intracrine induction of 11beta-hydroxysteroid dehydrogenase type 1 expression by glucocorticoid potentiates prostaglandin production in the human chorionic trophoblast [J]. Biol Reprod. 2002;67(5):1450-1455.
[63]. Sun K, Myatt L. Enhancement of glucocorticoid-induced 11 beta-hydroxysteroid dehydrogenase type 1 expression by proinflammatory cytokines in cultured human amnion fibroblasts [J]. Endocrinology. 2003;144(12):5568-5577.
[64]. Draper N, Echwald SM, Lavery GG, Walker EA, Fraser R, Davies E, Sorensen TI, Astrup A, Adamski J, Hewison M, Connell JM, Pedersen O, Stewart PM. Association studies between microsatellite markers within the gene encoding human 11beta-hydroxysteroid dehydrogenase type 1 and body mass index, waist to hip ratio, and glucocorticoid metabolism [J]. J Clin Endocrinol Metab. 2002;87(11):4984-4990.
[65]. Heitzer MD, Wolf IM, Sanchez ER, Witchel SF, DeFranco DB. Glucocorticoid receptor physiology [J]. Rev Endocr Metab Disord.2007;8(4):321-330.
[66]. Munck A, Brinck-Johnsen T. Specific and nonspecific physicochemical interactions of glucocorticoids and related steroids with rat thymus cells in vitro [J]. J Biol Chem.1968;243(21):5556-5565.
[67]. Hollenberg SM, Weinberger C, Ong ES, Cerelli G, Oro A, Lebo R, Thompson EB, Rosenfeld MG, Evans RM. Primary structure and expression of a functional human glucocorticoid receptor cDNA [J]. Nature. 1985;318(6047):635-641.
[68]. Ito K, Barnes PJ, Adcock IM. Glucocorticoid receptor recruitment of histone deacetylase 2 inhibits interleukin-1beta-induced histone H4 acetylation on lysines 8 and 12 [J]. Mol Cell Biol.2000;20(18):6891-6903.
[69]. Gottlicher M, Heck S, Herrlich P. Transcriptional cross-talk, the second mode of steroid hormone receptor action [J]. J Mol Med.1998;76(7):480-489.
[70]. Akira S, Isshiki H, Sugita T, Tanabe O, Kinoshita S, Nishio Y, Nakajima T, Hirano T, Kishimoto T. A nuclear factor for 1L-6 expression (NF-IL6) is a member of a C/EBP family [J].EMBOJ.1990;9(6):1897-1906.
[71]. Poli V, Mancini FP, Cortese R. IL-6DBP, a nuclear protein involved in interleukin-6 signal transduction, defines a new family of leucine zipper proteins related to C/EBP [J]. Cell.1990;63(3):643-653.
[72]. Descombes P, Chojkier M, Lichtsteiner S, Falvey E, Schibler U. LAP, a novel member of the C/EBP gene family, encodes a liver-enriched transcriptional activator protein [J]. Genes Dev.1990;4(9):1541-1551.
[73]. Chang CJ, Chen TT, Lei HY, Chen DS, Lee SC. Molecular cloning of a transcription factor, AGP/EBP, that belongs to members of the C/EBP family [J]. Mol Cell Biol.1990;10(12):6642-6653.
[74]. Roman C, Platero JS, Shuman J, Calame K. Ig/EBP-1:a ubiquitously expressed immunoglobulin enhancer binding protein that is similar to C/EBP and heterodimerizes with C/EBP [J]. Genes Dev.1990;4(8):1404-1415.
[75]. Cao Z, Umek RM, McKnight SL. Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells [J]. Genes Dev. 1991;5(9):1538-1552.
[76]. Williams SC, Cantwell CA, Johnson PF. A family of C/EBP-related proteins capable of forming covalently linked leucine zipper dimers in vitro [J]. Genes Dev.1991;5(9):1553-1567.
[77]. Ron D, Habener JF. CHOP, a novel developmentally regulated nuclear protein that dimerizes with transcription factors C/EBP and LAP and functions as a dominant-negative inhibitor of gene transcription [J]. Genes Dev. 1992;6(3):439-453.
[78]. Ramji DP, Foka P. CCAAT/enhancer-binding proteins:structure, function and regulation [J]. Biochem J.2002;365(Pt 3):561-575.
[79]. Lekstrom-Himes J, Xanthopoulos KG. Biological role of the CCAAT/enhancer-binding protein family of transcription factors [J]. J Biol Chem.1998;273(44):28545-28548.
[80]. Wedel A, Ziegler-Heitbrock HW. The C/EBP family of transcription factors [J]. Immunobiology.1995;193(2-4):171-185.
[81]. Cardinaux JR, Allaman I, Magistretti PJ. Pro-inflammatory cytokines induce the transcription factors C/EBPbeta and C/EBPdelta in astrocytes [J]. Glia. 2000;29(1):91-97.
[82]. Tengku-Muhammad TS, Hughes TR, Ranki H, Cryer A, Ramji DP. Differential regulation of macrophage CCAAT-enhancer binding protein isoforms by lipopolysaccharide and cytokines [J]. Cytokine. 2000;12(9):1430-1436.
[83]. Granger RL, Hughes TR, Ramji DP. Stimulus-and cell-type-specific regulation of CCAAT-enhancer binding protein isoforms in glomerular mesangial cells by lipopolysaccharide and cytokines [J]. Biochim Biophys Acta.2000;1501(2-3):171-179.
[84]. Yin M, Yang SQ, Lin HZ, Lane MD, Chatterjee S, Diehl AM. Tumor necrosis factor alpha promotes nuclear localization of cytokine-inducible CCAAT/enhancer binding protein isoforms in hepatocytes [J]. J Biol Chem. 1996;271(30):17974-17978.
[85]. Buck M, Zhang L, Halasz NA, Hunter T, Chojkier M. Nuclear export of phosphorylated C/EBPbeta mediates the inhibition of albumin expression by TNF-alpha [J]. EMBO J.2001;20(23):6712-6723.
[86]. Timchenko N, Wilson DR, Taylor LR, Abdelsayed S, Wilde M, Sawadogo M, Darlington GJ. Autoregulation of the human C/EBP alpha gene by stimulation of upstream stimulatory factor binding [J]. Mol Cell Biol. 1995;15(3):1192-1202.
[87]. MacDougald OA, Cornelius P, Lin FT, Chen SS, Lane MD. Glucocorticoids reciprocally regulate expression of the CCAAT/enhancer-binding protein alpha and delta genes in 3T3-L1 adipocytes and white adipose tissue [J]. J Biol Chem.1994;269(29):19041-19047.
[88]. Rana B, Xie Y, Mischoulon D, Bucher NL, Farmer SR. The DNA binding activity of C/EBP transcription factor is regulated in the G1 phase of the hepatocyte cell cycle [J]. J Biol Chem.1995;270(30):18123-18132.
[89]. Stephens JM, Pekala PH. Transcriptional repression of the C/EBP-alpha and GLUT4 genes in 3T3-L1 adipocytes by tumor necrosis factor-alpha. Regulations is coordinate and independent of protein synthesis [J]. J Biol Chem.1992;267(19):13580-13584.
[90]. Mahoney CW, Shuman J, McKnight SL, Chen HC, Huang KP. Phosphorylation of CCAAT-enhancer binding protein by protein kinase C attenuates site-selective DNA binding [J]. J Biol Chem. 1992;267(27):19396-19403.
[91]. Iannuzzi DM, Ertsey R, Ballard PL. Biphasic glucocorticoid regulation of pulmonary SP-A:characterization of inhibitory process [J]. Am J Physiol. 1993;264(3Pt1):L236-244.
[92]. Karinch AM, Deiter G, Ballard PL, Floros J. Regulation of expression of human SP-A1 and SP-A2 genes in fetal lung explant culture [J]. Biochim Biophys Acta.1998; 1398(2):192-202.
[93]. Whitsett JA, Weaver TE, Clark JC, Sawtell N, Glasser SW, Korfhagen TR, Hull WM. Glucocorticoid enhances surfactant proteolipid Phe and pVal synthesis and RNA in fetal lung [J]. J Biol Chem.1987;262(32):15618-15623.
[94]. Venkatesh VC, Iannuzzi DM, Ertsey R, Ballard PL. Differential glucocorticoid regulation of the pulmonary hydrophobic surfactant proteins SP-B and SP-C [J]. Am J Respir Cell Mol Biol.1993;8(2):222-228.
[95]. Venkatesh VC, Planer BC, Schwartz M, Vanderbilt JN, White RT, Ballard PL. Characterization of the promoter of human pulmonary surfactant protein B gene [J]. Am J Physiol.1995;268(4 Pt 1):L674-682.
[96]. Brieu V, Cathiard AM, Darbeida H, Naaman E, Saez JM, Durand P. Development of the fetal pituitary-adrenal axis in the sheep [J]. Reprod Nutr Dev.1988;28(4B):1129-1144.
[97]. Naaman Reperant E, Durand P. The development of the ovine fetal adrenal gland and its regulation [J]. Reprod Nutr Dev.1997;37(1):81-95.
[98]. Gitau R, Fisk NM, Teixeira JM, Cameron A, Glover V. Fetal hypothalamic-pituitary-adrenal stress responses to invasive procedures are independent of maternal responses [J]. J Clin Endocrinol Metab. 2001;86(1):104-109.
[99]. Mesiano S, Jaffe RB. Developmental and functional biology of the primate fetal adrenal cortex [J]. Endocr Rev.1997;18(3):378-403.
[100]. Ballard PL, Ning Y, Polk D, Ikegami M, Jobe AH. Glucocorticoid regulation of surfactant components in immature lambs [J]. Am J Physiol.1997;273(5 Pt 1):L1048-1057.
[101]. Tan RC, Ikegami M, Jobe AH, Yao LY, Possmayer F, Ballard PL Developmental and glucocorticoid regulation of surfactant protein mRNAs in preterm lambs [J]. Am J Physiol.1999;277(6 Pt 1):L1142-1148.
[102]. Liggins GC, Kitterman JA, Campos GA, Clements JA, Forster CS, Lee CH, Creasy RK. Pulmonary maturation in the hypophysectomised ovine fetus. Differential responses to adrenocorticotrophin and cortisol [J]. J Dev Physiol. 1981;3(1):1-14.
[103]. Kitterman JA, Liggins GC, Campos GA, Clements JA, Forster CS, Lee CH, Creasy RK. Prepartum maturation of the lung in fetal sheep:relation to cortisol [J]. J Appl Physiol.1981;51(2):384-390.
[104]. Crone RK, Davies P, Liggins GC, Reid L. The effects of hypophysectomy, thyroidectomy, and postoperative infusion of cortisol or adrenocorticotrophin on the structure of the ovine fetal lung [J]. J Dev Physiol.1983;5(5):281-288.
[105]. Hitchcock KR. Hormones and the lung. I. Thyroid hormones and glucocorticoids in lung development [J]. Anat Rec.1979; 194(1):15-39.
[106]. Muglia L, Jacobson L, Dikkes P, Majzoub JA. Corticotropin-releasing hormone deficiency reveals major fetal but not adult glucocorticoid need [J]. Nature.1995;373(6513):427-432.
[107]. Cole TJ, Blendy JA, Monaghan AP, Krieglstein K, Schmid W, Aguzzi A, Fantuzzi G, Hummler E, Unsicker K, Schutz G. Targeted disruption of the glucocorticoid receptor gene blocks adrenergic chromaffin cell development and severely retards lung maturation [J]. Genes Dev.1995;9(13):1608-1621.
[108]. Kikkawa Y, Kaibara M, Motoyama EK, Orzalesi MM, Cook CD. Morphologic development of fetal rabbit lung and its acceleration with cortisol [J]. Am J Pathol.1971;64(2)::423-442.
[109]. Bunton TE, Plopper CG. Triamcinolone-induced structural alterations in the development of the lung of the fetal rhesus macaque [J]. Am J Obstet Gynecol. 1984;148(2):203-215.
[110]. Challis JR, Sloboda D, Matthews SG, Holloway A, Alfaidy N, Patel FA, Whittle W, Fraser M, Moss TJ, Newnham J. The fetal placental hypothalamic-pituitary-adrenal (HPA) axis, parturition and post natal health [J]. Mol Cell Endocrinol.2001;185(1-2):135-144.
[111]. Beitins IZ, Bayard F, Ances IG, Kowarski A, Migeon CJ. The metabolic clearance rate, blood production, interconversion and transplacental passage of cortisol and cortisone in pregnancy near term [J]. Pediatr Res. 1973;7(5):509-519.
[112]. Campbell AL, Murphy BE. The maternal-fetal cortisol gradient during pregnancy and at delivery [J]. J Clin Endocrinol Metab.1977;45(3):435-440.
[113]. Murphy BE, Clark SJ, Donald IR, Pinsky M, Vedady D. Conversion of maternal cortisol to cortisone during placental transfer to the human fetus [J]. Am J Obstet Gynecol.1974;118(4):538-541.
[114]. Bernal AL, Flint AP, Anderson AB, Turnbull AC.11 beta-Hydroxyteroid dehydrogenase activity (E.C.1.1.1.146) in human placenta and decidua [J]. J Steroid Biochem.1980;13(9):1081-1087.
[115]. de Fencl M, Tulchinsky D. Total cortisol in amniotic fluid and fetal lung maturation [J]. N Engl J Med.1975;292(3):133-136.
[116]. Sippell WG, Muller-Holve W, Dorr HG, Bidlingmaier F, Knorr D. Concentrations of aldosterone, corticosterone,11-deoxycorticosterone, progesterone,17-hydroxyprogesterone,11-deoxycortisol, cortisol, and cortisone determined simultaneously in human amniotic fluid throughout gestation [J]. J Clin Endocrinol Metab.1981;52(3):385-392.
[117]. Krozowski Z, Li KX, Koyama K, Smith RE, Obeyesekere VR, Stein-Oakley A, Sasano H, Coulter C, Cole T, Sheppard KE. The type Ⅰ and type Ⅱ 11beta-hydroxysteroid dehydrogenase enzymes [J]. J Steroid Biochem Mol Biol.1999;69(1-6):391-401.
[118]. Thompson A, Han VK, Yang K. Differential expression of 11beta-hydroxysteroid dehydrogenase types 1 and 2 mRNA and glucocorticoid receptor protein during mouse embryonic development [J]. J Steroid Biochem Mol Biol.2004;88(4-5):367-375.
[119]. Speirs HJ, Seckl JR, Brown RW. Ontogeny of glucocorticoid receptor and 11beta-hydroxysteroid dehydrogenase type-1 gene expression identifies potential critical periods of glucocorticoid susceptibility during development [J]. J Endocrinol.2004;181(1):105-116.
[120]. Hundertmark S, Dill A, Buhler H, Stevens P, Looman K, Ragosch V, Seckl JR, Lipka C.11 beta-hydroxysteroid dehydrogenase type 1:a new regulator of fetal lung maturation [J]. Horm Metab Res.2002;34(10):537-544.
[121]. Gnanalingham MG, Mostyn A, Gardner DS, Stephenson T, Symonds ME. Developmental regulation of the lung in preparation for life after birth: hormonal and nutritional manipulation of local glucocorticoid action and uncoupling protein-2 [J]. J Endocrinol.2006;188(3):375-386.
[122]. Krozowski Z, MaGuire JA, Stein-Oakley AN, Dowling J, Smith RE, Andrews RK. Immunohistochemical localization of the 11 beta-hydroxysteroid dehydrogenase type II enzyme in human kidney and placenta [J]. J Clin Endocrinol Metab.1995;80(7):2203-2209.
[123]. Albiston AL, Obeyesekere VR, Smith RE, Krozowski ZS. Cloning and tissue distribution of the human 11 beta-hydroxysteroid dehydrogenase type 2 enzyme [J]. Mol Cell Endocrinol.1994; 105(2):R11-17.
[124]. Shams M, Kilby MD, Somerset DA, Howie AJ, Gupta A, Wood PJ, Afnan M, Stewart PM.11 Beta-hydroxysteroid dehydrogenase type 2 in human pregnancy and reduced expression in intrauterine growth restriction [J]. Hum Reprod.1998;13(4):799-804.
[125]. Garbrecht MR, Schmidt TJ, Krozowski ZS, Snyder JM. 11 Beta-hydroxysteroid dehydrogenase type 2 and the regulation of surfactant protein A by dexamethasone metabolites [J]. Am J Physiol Endocrinol Metab. 2006;290(4):E653-660.
[126]. Stewart PM, Rogerson FM, Mason JI. Type 2 11 beta-hydroxysteroid dehydrogenase messenger ribonucleic acid and activity in human placenta and fetal membranes:its relationship to birth weight and putative role in fetal adrenal steroidogenesis [J]. J Clin Endocrinol Metab.1995;80(3):885-890.
[127]. Murphy BE. Cortisol production and inactivation by the human lung during gestation and infancy [J]. J Clin Endocrinol Metab.1978;47(2):243-248.
[128]. Yang Z, Zhu P, Guo C, Zhu X, Sun K. Expression of 11 beta-hydroxysteroid dehydrogenase type 1 in human fetal lung and regulation of its expression by interleukin-1beta and cortisol [J]. J Clin Endocrinol Metab. 2009;94(1):306-313.
[129]. Cole TJ. Cloning of the mouse 11 beta-hydroxysteroid dehydrogenase type 2 gene:tissue specific expression and localization in distal convoluted tubules and collecting ducts of the kidney [J]. Endocrinology. 1995;136(10):4693-4696.
[130]. Brown RW, Diaz R, Robson AC, Kotelevtsev YV, Mullins JJ, Kaufman MH, Seckl JR. The ontogeny of 11 beta-hydroxysteroid dehydrogenase type 2 and mineralocorticoid receptor gene expression reveal intricate control of glucocorticoid action in development [J]. Endocrinology. 1996;137(2):794-797.
[131]. Abramovitz M, Carriero R, Murphy BE. Investigation of factors influencing 11 beta-hydroxysteroid dehydrogenase (EC 1.1.1.146) activity in midgestational human fetal lung monolayer and explant cultures [J]. J Steroid Biochem.1984;21(6):677-683.
[132]. Murphy BE. Ontogeny of cortisol-cortisone interconversion in human tissues: a role for cortisone in human fetal development [J]. J Steroid Biochem. 1981;14(9):811-817.
[133]. Alberts P, Nilsson C, Selen G, Engblom LO, Edling NH, Norling S, Klingstrom G, Larsson C, Forsgren M, Ashkzari M, Nilsson CE, Fiedler M, Bergqvist E, Ohman B, Bjorkstrand E, Abrahmsen LB. Selective inhibition of 11 beta-hydroxysteroid dehydrogenase type 1 improves hepatic insulin sensitivity in hyperglycemic mice strains [J]. Endocrinology. 2003;144(11):4755-4762.
[134]. Wang GM, Ge RS, Latif SA, Morris DJ, Hardy MP. Expression of 11 beta-hydroxylase in rat Leydig cells [J]. Endocrinology. 2002;143(2):621-626.
[135]. Suzuki S, Tsubochi H, Darnel A, Suzuki T, Sasano H, Krozowski ZS, Kondo T. Expression of 11 beta-hydroxysteroid dehydrogenase type 1 in alveolar epithelial cells in rats [J]. Endocr J.2003;50(4):445-451.
[136]. Swaab DF, Visser M, Tilders FJ. Stimulation of intra-uterine growth in rat by alpha-melanocyte-stimulating hormone [J]. J Endocrinol.1976;70(3):445-455.
[137]. Deayton JM, Young IR, Hollingworth SA, White A, Crosby SR, Thorburn GD. Effect of late hypothalamo-pituitary disconnection on the development of the HPA axis in the ovine fetus and the initiation of parturition [J]. J Neuroendocrinol.1994;6(1):25-31.
[138]. Ohrlander S, Gennser G, Eneroth P. Plasma cortisol levels in human fetus during parturition [J]. Obstet Gynecol.1976;48(4):381-387.
[139]. Whittle WL, Patel FA, Alfaidy N, Holloway AC, Fraser M, Gyomorey S, Lye SJ, Gibb W, Challis JR. Glucocorticoid regulation of human and ovine parturition:the relationship between fetal hypothalamic-pituitary-adrenal axis activation and intrauterine prostaglandin production [J]. Biol Reprod. 2001;64(4):1019-1032.
[140]. Goldkrand JW, Schulte RL, Messer RH. Maternal and fetal plasma cortisol levels at parturition [J]. Obstet Gynecol.1976;47(1):41-45.
[141]. Albrecht ED, Pepe GJ. Placental steroid hormone biosynthesis in primate pregnancy [J]. Endocr Rev.1990;11(1):124-150.
[142]. Pepe GJ, Albrecht ED. Regulation of the primate fetal adrenal cortex [J]. Endocr Rev.1990;11(1):151-176.
[143]. Granberg JP, Ballard PL. The role of sulfhydryl groups in the binding of glucocorticoids by cytoplasmic receptors of lung and other mammalian tissues [J]. Endocrinology.1977; 100(4):1160-1168.
[144]. Ballard PL, Ballard RA. Cytoplasmic receptor for glucocorticoids in lung of the human fetus and neonate [J]. J Clin Invest.1974;53(2):477-486.
[145]. Seckl JR.11 beta-hydroxysteroid dehydrogenase isoforms and their implications for blood pressure regulation [J]. Eur J Clin Invest. 1993;23(10):589-601.
[146]. Murphy BE. Chorionic membrane as an extra-adrenal source of foetal cortisol in human amniotic fluid [J]. Nature.1977;266(5598):179-181.
[147]. Li W, Gao L, Wang Y, Duan T, Myatt L, Sun K. Enhancement of cortisol-induced 11 beta-hydroxysteroid dehydrogenase type 1 expression by interleukin lbeta in cultured human chorionic trophoblast cells [J]. Endocrinology.2006;147(5):2490-2495.
[148]. Napolitano A, Voice MW, Edwards CR, Seckl JR, Chapman KE. 11 Beta-hydroxysteroid dehydrogenase 1 in adipocytes:expression is differentiation-dependent and hormonally regulated [J]. J Steroid Biochem Mol Biol.1998;64(5-6):251-260.
[149]. Tomlinson JW, Moore J, Cooper MS, Bujalska I, Shahmanesh M, Burt C, Strain A, Hewison M, Stewart PM. Regulation of expression of 11 beta-hydroxysteroid dehydrogenase type 1 in adipose tissue:tissue-specific induction by cytokines [J]. Endocrinology.2001;142(5):1982-1989.
[150]. Cai TQ, Wong B, Mundt SS, Thieringer R, Wright SD, Hermanowski-Vosatka A. Induction of 11 beta-hydroxysteroid dehydrogenase type 1 but not-2 in human aortic smooth muscle cells by inflammatory stimuli [J]. J Steroid Biochem Mol Biol.2001;77(2-3):117-122.
[151]. Whorwood CB, Donovan SJ, Flanagan D, Phillips DI, Byrne CD. Increased glucocorticoid receptor expression in human skeletal muscle cells may contribute to the pathogenesis of the metabolic syndrome [J]. Diabetes. 2002;51(4):1066-1075.
[152]. Wang Z, Tai HH. Interleukin-1 beta and dexamethasone regulate gene expression of prostaglandin H synthase-2 via the NF-kB pathway in human amnion derived WISH cells [J]. Prostaglandins Leukot Essent Fatty Acids. 1998;59(1):63-69.
[153]. Pryhuber GS, Khalak R, Zhao Q. Regulation of surfactant proteins A and B by TNF-alpha and phorbol ester independent of NF-kappa B [J]. Am J Physiol. 1998;274(2Pt1):L289-295.
[154]. Wissink S, van Heerde EC, vand der Burg B, van der Saag PT. A dual mechanism mediates repression of NF-kappaB activity by glucocorticoids [J]. Mol Endocrinol.1998;12(3):355-363.
[155]. McKay LI, Cidlowski JA. Cross-talk between nuclear factor-kappa B and the steroid hormone receptors:mechanisms of mutual antagonism [J]. Mol Endocrinol.1998;12(1):45-56.
[156]. Gunn L, Hardiman P, Tharmaratnam S, Lowe D, Chard T. Measurement of interleukin-1 alpha and interleukin-6 in pregnancy-associated tissues [J]. Reprod Fertil Dev.1996;8(7):1069-1073.
[157]. Romero R, Parvizi ST, Oyarzun E, Mazor M, Wu YK, Avila C, Athanassiadis AP, Mitchell MD. Amniotic fluid interleukin-1 in spontaneous labor at term [J]. J Reprod Med.1990;35(3):235-238.
[158]. Opsjln SL, Wathen NC, Tingulstad S, Wiedswang G, Sundan A, Waage A, Austgulen R. Tumor necrosis factor, interleukin-1, and interleukin-6 in normal human pregnancy [J]. Am J Obstet Gynecol.1993;169(2 Pt 1):397-404.
[159]. Olah KS, Vince GS, Neilson JP, Deniz G, Johnson PM. Interleukin-6, interferon-gamma, interleukin-8, and granulocyte-macrophage colony stimulating factor levels in human amniotic fluid at term [J]. J Reprod Immunol.1996;32(1):89-98.
[160]. Laham N, Brennecke SP, Bendtzen K, Rice GE. Differential release of interleukin-6 from human gestational tissues in association with labour and in vitro endotoxin treatment [J]. J Endocrinol.1996;149(3):431-439.
[161]. Saito S, Kasahara T, Kato Y, Ishihara Y, Ichijo M. Elevation of amniotic fluid interleukin 6 (IL-6), IL-8 and granulocyte colony stimulating factor (G-CSF) in term and preterm parturition [J]. Cytokine.1993;5(1):81-88.
[162]. Santhanam U, Avila C, Romero R, Viguet H, Ida N, Sakurai S, Sehgal PB. Cytokines in normal and abnormal parturition:elevated amniotic fluid interleukin-6 levels in women with premature rupture of membranes associated with intrauterine infection [J]. Cytokine.1991;3(2):155-163.
[163]. Romero R, Mazor M, Sepulveda W, Avila C, Copeland D, Williams J. Tumor necrosis factor in preterm and term labor [J]. Am J Obstet Gynecol. 1992;166(5):1576-1587.
[164]. Wang EE, Ohlsson A, Kellner JD. Association of Ureaplasma urealyticum colonization with chronic lung disease of prematurity:results of a metaanalysis [J]. J Pediatr.1995;127(4):640-644.
[165]. Yoon BH, Romero R, Park JS, Chang JW, Kim YA, Kim JC, Kim KS. Microbial invasion of the amniotic cavity with Ureaplasma urealyticum is associated with a robust host response in fetal, amniotic, and maternal compartments [J]. Am J Obstet Gynecol.1998;179(5):1254-1260.
[166]. Sun K, Yang K, Challis JR. Differential expression of 11 beta-hydroxysteroid dehydrogenase types 1 and 2 in human placenta and fetal membranes [J]. J Clin Endocrinol Metab.1997;82(1):300-305.
[167]. Kiaei M, Kipiani K, Petri S, Choi DK, Chen J, Calingasan NY, Beal MF. Integrative role of cPLA with COX-2 and the effect of non-steriodal anti-inflammatory drugs in a transgenic mouse model of amyotrophic lateral sclerosis [J]. J Neurochem.2005;93(2):403-411.
[168]. Porreca E, Reale M, Di Febbo C, Di Gioacchino M, Barbacane RC, Castellani ML, Baccante G, Conti P, Cuccurullo F. Down-regulation of cyclooxygenase-2 (COX-2) by interleukin-1 receptor antagonist in human monocytes [J]. Immunology.1996;89(3):424-429.
[169]. Samad TA, Moore KA, Sapirstein A, Billet S, Allchorne A, Poole S, Bonventre JV, Woolf CJ. Interleukin-1beta-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity [J]. Nature. 2001;410(6827):471-475.
[170]. Dieter P, Scheibe R, Kamionka S, Kolada A. LPS-induced synthesis and release of PGE2 in liver macrophages:regulation by CPLA2, COX-1, COX-2, and PGE2 synthase [J]. Adv Exp Med Biol.2002;507:457-462.
[171]. Lin CC, Lin WN, Wang WJ, Sun CC, Tung WH, Wang HH, Yang CM. Functional coupling expression of COX-2 and cPLA2 induced by ATP in rat vascular smooth muscle cells:role of ERK1/2, p38 MAPK, and NF-kappaB [J]. Cardiovasc Res.2009;82(3):522-531.
[172]. Hammami MM, Siiteri PK. Regulation of 11 beta-hydroxysteroid dehydrogenase activity in human skin fibroblasts:enzymatic modulation of glucocorticoid action [J]. J Clin Endocrinol Metab.1991;73(2):326-334.
[173]. Bujalska I, Shimojo M, Howie A, Stewart PM. Human 11 beta-hydroxysteroid dehydrogenase:studies on the stably transfected isoforms and localization of the type 2 isozyme within renal tissue [J]. Steroids.1997;62(1):77-82.
[174]. Blankstein J, Fujieda K, Reyes FI, Faiman C, Winter JS. Cortisol, 11-desoxycortisol, and 21-desoxycortisol concentrations in amniotic fluid during normal pregnancy [J]. Am J Obstet Gynecol.1980;137(7):781-784.
[175]. Muglia LJ, Katz M. The enigma of spontaneous preterm birth [J]. N Engl J Med.362(6):529-535.
[176]. Yoon BH, Romero R, Jun JK, Park KH, Park JD, Ghezzi F, Kim BI. Amniotic fluid cytokines (interleukin-6, tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8) and the risk for the development of bronchopulmonary dysplasia [J]. Am J Obstet Gynecol.1997;177(4):825-830.
[177]. Yoon BH, Romero R, Kim KS, Park JS, Ki SH, Kim BI, Jun JK. A systemic fetal inflammatory response and the development of bronchopulmonary dysplasia [J]. Am J Obstet Gynecol.1999;181(4):773-779.
[178]. Jobe AH, Newnham JP, Willet KE, Moss TJ, Gore Ervin M, Padbury JF, Sly P, Ikegami M. Endotoxin-induced lung maturation in preterm lambs is not mediated by cortisol [J]. Am J Respir Crit Care Med.2000; 162(5):1656-1661.
[179]. Speer CP. Inflammation and bronchopulmonary dysplasia [J]. Semin Neonatol. 2003;8(1):29-38.
[180]. Watterberg KL, Demers LM, Scott SM, Murphy S. Chorioamnionitis and early lung inflammation in infants in whom bronchopulmonary dysplasia develops [J]. Pediatrics.1996;97(2):210-215.
[181]. Hannaford K, Todd DA, Jeffery H, John E, Blyth K, Gilbert GL. Role of ureaplasma urealyticum in lung disease of prematurity [J]. Arch Dis Child Fetal Neonatal Ed.1999;81(3):F162-167.
[182]. Yoon BH, Jun JK, Romero R, Park KH, Gomez R, Choi JH, Kim IO. Amniotic fluid inflammatory cytokines (interleukin-6, interleukin-lbeta, and tumor necrosis factor-alpha), neonatal brain white matter lesions, and cerebral palsy [J]. Am J Obstet Gynecol.1997;177(1):19-26.
[183]. Duncan JR, Cock ML, Scheerlinck JP, Westcott KT, McLean C, Harding R, Rees SM. White matter injury after repeated endotoxin exposure in the preterm ovine fetus [J]. Pediatr Res.2002;52(6):941-949.
[184]. Watterberg KL, Scott SM, Naeye RL. Chorioamnionitis, cortisol, and acute lung disease in very low birth weight infants [J]. Pediatrics.1997;99(2):E6.
[185]. Seckl JR. 11beta-hydroxysteroid dehydrogenases:changing glucocorticoid action [J]. Curr Opin Pharmacol.2004;4(6):597-602.
[186]. Yong PY, Harlow C, Thong KJ, Hillier SG. Regulation of 11beta-hydroxy steroid dehydrogenase type 1 gene expression in human ovarian surface epithelial cells by interleukin-1 [J]. Hum Reprod. 2002;17(9):2300-2306.
[187]. Hardy RS, Filer A, Cooper MS, Parsonage G, Raza K, Hardie DL, Rabbitt EH, Stewart PM, Buckley CD, Hewison M. Differential expression, function and response to inflammatory stimuli of 11 beta-hydroxysteroid dehydrogenase type 1 in human fibroblasts:a mechanism for tissue-specific regulation of inflammation [J]. Arthritis Res Ther.2006;8(4):R108.
[188]. Hardy R, Rabbitt EH, Filer A, Emery P, Hewison M, Stewart PM, Gittoes NJ, Buckley CD, Raza K, Cooper MS. Local and systemic glucocorticoid metabolism in inflammatory arthritis [J]. Ann Rheum Dis. 2008;67(9):1204-1210.
[189]. Arai N, Masuzaki H, Tanaka T, Ishii T, Yasue S, Kobayashi N, Tomita T, Noguchi M, Kusakabe T, Fujikura J, Ebihara K, Hirata M, Hosoda K, Hayashi T, Sawai H, Minokoshi Y, Nakao K. Ceramide and adenosine 5'-monophosphate-activated protein kinase are two novel regulators of 11beta-hydroxysteroid dehydrogenase type 1 expression and activity in cultured preadipocytes [J]. Endocrinology.2007;148(11):5268-5277.
[190]. Cooper MS, Bujalska I, Rabbitt E, Walker EA, Bland R, Sheppard MC, Hewison M, Stewart PM. Modulation of 11 beta-hydroxysteroid dehydrogenase isozymes by proinflammatory cytokines in osteoblasts:an autocrine switch from glucocorticoid inactivation to activation [J]. J Bone Miner Res.2001;16(6):1037-1044.
[191]. Gilmour JS, Coutinho AE, Cailhier JF, Man TY, Clay M, Thomas G, Harris HJ, Mullins JJ, Seckl JR, Savill JS, Chapman KE. Local amplification of glucocorticoids by 11 beta-hydroxysteroid dehydrogenase type 1 promotes macrophage phagocytosis of apoptotic leukocytes [J]. J Immunol. 2006;176(12):7605-7611.
[192]. Greenman IC, Gomez E, Moore CE, Herbert TP. Distinct glucose-dependent stress responses revealed by translational profiling in pancreatic beta-cells [J]. J Endocrinol.2007; 192(1):179-187.
[193]. Anderson P, Phillips K, Stoecklin G, Kedersha N. Post-transcriptional regulation of proinflammatory proteins [J]. J Leukoc Biol.2004;76(1):42-47.
[194]. Blackshear PJ. Tristetraprolin and other CCCH tandem zinc-finger proteins in the regulation of mRNA turnover [J]. Biochem Soc Trans.2002;30(Pt 6):945-952.
[195]. Brivanlou AH, Darnell JE, Jr. Signal transduction and the control of gene expression [J]. Science.2002;295(5556):813-818.
[196]. Korhonen R, Lahti A, Hamalainen M, Kankaanranta H, Moilanen E. Dexamethasone inhibits inducible nitric-oxide synthase expression and nitric oxide production by destabilizing mRNA in lipopolysaccharide-treated macrophages [J]. Mol Pharmacol.2002;62(3):698-704.
[197]. Ozaki T, Habara K, Matsui K, Kaibori M, Kwon AH, Ito S, Nishizawa M, Okumura T. Dexamethasone inhibits the induction of iNOS gene expression through destabilization of its mRNA in proinflammatory cytokine-stimulated hepatocytes [J]. Shock.33(1):64-69.
[198]. Francke U, Foellmer BE. The glucocorticoid receptor gene is in 5q31-q32 [corrected] [J]. Genomics.1989;4(4):610-612.
[199]. Oakley RH, Sar M, Cidlowski JA. The human glucocorticoid receptor beta isoform. Expression, biochemical properties, and putative function [J]. J Biol Chem.1996;271(16):9550-9559.
[200]. Sanchez ER, Toft DO, Schlesinger MJ, Pratt WB. Evidence that the 90-kDa phosphoprotein associated with the untransformed L-cell glucocorticoid receptor is a murine heat shock protein [J]. J Biol Chem. 1985;260(23):12398-12401.
[201]. Beato M, Arnemann J, Chalepakis G, Slater E, Willmann T. Gene regulation by steroid hormones [J]. J Steroid Biochem.1987;27(1-3):9-14.
[202]. Williams LJ, Lyons V, MacLeod I, Rajan V, Darlington GJ, Poli V, Seckl JR, Chapman KE. C/EBP regulates hepatic transcription of 11 beta-hydroxysteroid dehydrogenase type 1. A novel mechanism for cross-talk between the C/EBP and glucocorticoid signaling pathways [J]. J Biol Chem. 2000;275(39):30232-30239.
[203]. Gout J, Tirard J, Thevenon C, Riou JP, Begeot M, Naville D. CCAAT/enhancer-biinding proteins (C/EBPs) regulate the basal and cAMP-induced transcription of the human llbeta-hydroxy steroid dehydrogenase encoding gene in adipose cells [J]. Biochimie. 2006;88(9):1115-1124.
[204]. Baumann H, Jahreis GP, Morella KK, Won KA, Pruitt SC, Jones VE, Prowse KR. Transcriptional regulation through cytokine and glucocorticoid response elements of rat acute phase plasma protein genes by C/EBP and JunB [J]. J Biol Chem.1991;266(30):20390-20399.
[205]. Alam T, An MR, Papaconstantinou J. Differential expression of three C/EBP isoforms in multiple tissues during the acute phase response [J]. J Biol Chem. 1992;267(8):5021-5024.
[206]. Birkenmeier EH, Gwynn B, Howard S, Jerry J, Gordon JI, Landschulz WH, McKnight SL. Tissue-specific expression, developmental regulation, and genetic mapping of the gene encoding CCAAT/enhancer binding protein [J]. Genes Dev.1989;3(8):1146-1156.
[207]. Li F, Rosenberg E, Smith CI, Notarfrancesco K, Reisher SR, Shuman H, Feinstein SI. Correlation of expression of transcription factor C/EBP alpha and surfactant protein genes in lung cells [J]. Am J Physiol.1995;269(2 Pt 1):L241-247.
[208]. Cassel TN, Nord M. C/EBP transcription factors in the lung epithelium [J]. Am J Physiol Lung Cell Mol Physiol.2003;285(4):L773-781.
[209]. Martis PC, Whitsett JA, Xu Y, Perl AK, Wan H, Ikegami M. C/EBPalpha is required for lung maturation at birth [J]. Development. 2006;133(6):1155-1164.
[210]. Flodby P, Barlow C, Kylefjord H, Ahrlund-Richter L, Xanthopoulos KG. Increased hepatic cell proliferation and lung abnormalities in mice deficient in CCAAT/enhancer binding protein alpha [J]. J Biol Chem. 1996;271(40):24753-24760.
[211]. Wang ND, Finegold MJ, Bradley A, Ou CN, Abdelsayed SV, Wilde MD, Taylor LR, Wilson DR, Darlington GJ. Impaired energy homeostasis in C/EBP alpha knockout mice [J]. Science.1995;269(5227):1108-1112.
[212]. Tanaka T, Yoshida N, Kishimoto T, Akira S. Defective adipocyte differentiation in mice lacking the C/EBPbeta and/or C/EBPdelta gene [J]. EMBO J.1997;16(24):7432-7443.
[213]. Rishi V, Gal J, Krylov D, Fridriksson J, Boysen MS, Mandrup S, Vinson C. SREBP-1 dimerization specificity maps to both the helix-loop-helix and leucine zipper domains:use of a dominant negative [J]. J Biol Chem. 2004;279(12):11863-11874.
[214]. Olive M, Williams SC, Dezan C, Johnson PF, Vinson C. Design of a C/EBP-specific, dominant-negative bZIP protein with both inhibitory and gain-of-function properties [J]. J Biol Chem.1996;271(4):2040-2047.
[215]. Chapman KE, Coutinho A, Gray M, Gilmour JS, Savill JS, Seckl JR. Local amplification of glucocorticoids by 11 beta-hydroxysteroid dehydrogenase type 1 and its role in the inflammatory response [J]. Ann N Y Acad Sci. 2006;1088:265-273.
[216]. Stimson RH, Walker BR. Glucocorticoids and 11 beta-hydroxysteroid dehydrogenase type 1 in obesity and the metabolic syndrome [J]. Minerva Endocrinol.2007;32(3):141-159.
[217]. Hecker M, Preiss C, Schini-Kerth VB. Induction by staurosporine of nitric oxide synthase expression in vascular smooth muscle cells:role of NF-kappa B, CREB and C/EBP beta [J]. Br J Pharmacol.1997; 120(6):1067-1074.
[218]. Fukuoka T, Kitami Y, Okura T, Hiwada K. Transcriptional regulation of the platelet-derived growth factor alpha receptor gene via CCAAT/enhancer-binding protein-delta in vascular smooth muscle cells [J]. J Biol Chem.1999;274(36):25576-25582.
[219]. Bujalska IJ, Kumar S, Stewart PM. Does central obesity reflect "Cushing's disease of the omentum"? [J]. Lancet.1997;349(9060):1210-1213.
[220]. Masuzaki H, Paterson J, Shinyama H, Morton NM, Mullins JJ, Seckl JR, Flier JS. A transgenic model of visceral obesity and the metabolic syndrome [J]. Science.2001;294(5549):2166-2170.
[221]. Sai S, Esteves CL, Kelly V, Michailidou Z, Anderson K, Coll AP, Nakagawa Y, Ohzeki T, Seckl JR, Chapman KE. Glucocorticoid regulation of the promoter of 11beta-hydroxysteroid dehydrogenase type 1 is indirect and requires CCAAT/enhancer-binding protein-beta [J]. Mol Endocrinol. 2008;22(9):2049-2060.
[222]. Bruley C, Lyons V, Worsley AG, Wilde MD, Darlington GD, Morton NM, Seckl JR, Chapman KE. A novel promoter for the llbeta-hydroxysteroid dehydrogenase type 1 gene is active in lung and is C/EBPalpha independent [J]. Endocrinology.2006;147(6):2879-2885.
[223]. Chapman KE, Coutinho AE, Gray M, Gilmour JS, Savill JS, Seckl JR. The role and regulation of 11beta-hydroxysteroid dehydrogenase type 1 in the inflammatory response [J]. Mol Cell Endocrinol.2009;301(1-2):123-131.
[224]. Yang Z, Zhu X, Guo C, Sun K. Stimulation of llbeta-HSD1 expression by IL-lbeta via a C/EBP binding site in human fetal lung fibroblasts [J]. Endocrine.2009.
[225]. Ignatova ID, Kostadinova RM, Goldring CE, Nawrocki AR, Frey FJ, Frey BM. Tumor necrosis factor-alpha upregulates 11beta-hydroxysteroid dehydrogenase type 1 expression by CCAAT/enhancer binding protein-beta in HepG2 cells [J]. Am J Physiol Endocrinol Metab.2009;296(2):E367-377.
[226]. Tsugita M, Iwasaki Y, Nishiyama M, Taguchi T, Shinahara M, Taniguchi Y, Kambayashi M, Terada Y, Hashimoto K. Differential regulation of 11beta-hydroxysteroid dehydrogenase type-1 and-2 gene transcription by proinflammatory cytokines in vascular smooth muscle cells [J]. Life Sci. 2008;83(11-12):426-432.
[227]. Iwasaki Y, Takayasu S, Nishiyama M, Tsugita M, Taguchi T, Asai M, Yoshida M, Kambayashi M, Hashimoto K. Is the metabolic syndrome an intracellular Cushing state? Effects of multiple humoral factors on the transcriptional activity of the hepatic glucocorticoid-activating enzyme (11 beta-hydroxysteroid dehydrogenase type 1) gene [J]. Mol Cell Endocrinol. 2008;285(1-2):10-18.
[228]. Basseres DS, Levantini E, Ji H, Monti S, Elf S, Dayaram T, Fenyus M, Kocher O, Golub T, Wong KK, Halmos B, Tenen DG. Respiratory failure due to differentiation arrest and expansion of alveolar cells following lung-specific loss of the transcription factor C/EBPalpha in mice [J]. Mol Cell Biol. 2006;26(3):1109-1123.
[229]. Rosenberg E, Li F, Reisher SR, Wang M, Gonzales LW, Ewing JR, Malek S, Ballard PL, Notarfrancesco K, Shuman H, Feinstein SI. Members of the C/EBP transcription factor family stimulate expression of the human and rat surfactant protein A (SP-A) genes [J]. Biochim Biophys Acta. 2002;1575(1-3):82-90.
[230]. Seidner S, Pettenazzo A, Ikegami M, Jobe A. Corticosteroid potentiation of surfactant dose response in preterm rabbits [J]. J Appl Physiol. 1988;64(6):2366-2371.
[231]. Johnson JW, Mitzner W, London WT, Palmer AE, Scott R, Kearney K. Glucocorticoids and the rhesus fetal lung [J]. Am J Obstet Gynecol. 1978; 130(8):905-916.
[232]. Platzker AC, Kitterman JA, Mescher EJ, Clements JA, Tooley WH. Surfactant in the lung and tracheal fluid of the fetal lamb and acceleration of its appearance by dexamethasone [J]. Pediatrics.1975;56(4):554-561.
[233]. Rooney SA, Young SL, Mendelson CR. Molecular and cellular processing of lung surfactant [J]. FASEB J.1994;8(12):957-967.
[234]. Gonzales LW, Ertsey R, Ballard PL, Froh D, Goerke J, Gonzales J. Glucocorticoid stimulation of fatty acid synthesis in explants of human fetal lung [J]. Biochim Biophys Acta.1990;1042(1):1-12.
[235]. Wagle S, Bui A, Ballard PL, Shuman H, Gonzales J, Gonzales LW. Hormonal regulation and cellular localization of fatty acid synthase in human fetal lung [J]. Am J Physiol.1999;277(2 Pt 1):L381-390.
[236]. Hillgartner FB, Salati LM, Goodridge AG. Physiological and molecular mechanisms involved in nutritional regulation of fatty acid synthesis [J]. Physiol Rev.1995;75(1):47-76.
[237]. Smith S. The animal fatty acid synthase:one gene, one polypeptide, seven enzymes [J]. FASEB J.1994;8(15):1248-1259.
[238]. Wakil SJ, Stoops JK, Joshi VC. Fatty acid synthesis and its regulation [J]. Annu Rev Biochem.1983;52:537-579.
[239]. Pope TS, Smart DA, Rooney SA. Hormonal effects on fatty-acid synthase in cultured fetal rat lung; induction by dexamethasone and inhibition of activity by triiodothyronine [J]. Biochim Biophys Acta.1988;959(2):169-177.
[240]. Boggaram V, Mendelson CR. Transcriptional regulation of the gene encoding the major surfactant protein (SP-A) in rabbit fetal lung [J]. J Biol Chem. 1988;263(35):19060-19065.
[241]. Warr RG, Hawgood S, Buckley DI, Crisp TM, Schilling J, Benson BJ, Ballard PL, Clements JA, White RT. Low molecular weight human pulmonary surfactant protein (SP5):isolation, characterization, and cDNA and amino acid sequences [J]. Proc Natl Acad Sci U S A.1987;84(22):7915-7919.
[242]. Rooney SA, Gobran LI, Chu AJ. Thyroid hormone opposes some glucocorticoid effects on glycogen content and lipid synthesis in developing fetal rat lung [J]. Pediatr Res.1986;20(6):545-550.
[243]. Maniscalco WM, Finkelstein JN, Parkhurst AB. Dexamethasone increases de novo fatty acid synthesis in fetal rabbit lung explants [J]. Pediatr Res. 1985;19(12):1272-1277.
[244]. Xu ZX, Stenzel W, Sasic SM, Smart DA, Rooney SA. Glucocorticoid regulation of fatty acid synthase gene expression in fetal rat lung [J]. Am J Physiol.1993;265(2Pt 1):L140-147.
[245]. Xu ZX, Viviano CJ, Rooney SA. Glucocorticoid stimulation of fatty-acid synthase gene transcription in fetal lung:antagonism by retinoic acid [J]. Am J Physiol.1995;268(4Pt 1):L683-690.
[246]. Xu ZX, Rooney SA. Glucocorticoids increase fatty-acid synthase mRNA stability in fetal rat lung [J]. Am J Physiol.1997;272(5 Pt 1):L860-864.
[247]. Hawgood S, Clements JA. Pulmonary surfactant and its apoproteins [J]. J Clin Invest.1990;86(1):1-6.
[248]. Weaver TE, Whitsett JA. Function and regulation of expression of pulmonary surfactant-associated proteins [J]. Biochem J.1991;273(Pt 2):249-264.
[249]. Clark JC, Weaver TE, Iwamoto HS, Ikegami M, Jobe AH, Hull WM, Whitsett JA. Decreased lung compliance and air trapping in heterozygous SP-B-deficient mice [J]. Am J Respir Cell Mol Biol.1997;16(1):46-52.
[250]. Ballard PL, Hawgood S, Liley H, Wellenstein G, Gonzales LW, Benson B, Cordell B, White RT. Regulation of pulmonary surfactant apoprotein SP 28-36 gene in fetal human lung [J]. Proc Natl Acad Sci U S A. 1986;83(24):9527-9531.
[251]. Liley HG, Hawgood S, Wellenstein GA, Benson B, White RT, Ballard PL. Surfactant protein of molecular weight 28,000-36,000 in cultured human fetal lung:cellular localization and effect of dexamethasone [J]. Mol Endocrinol. 1987;1(3):205-215.
[252]. O'Reilly MA, Gazdar AF, Clark JC, Pilot-Matias TJ, Wert SE, Hull WM, Whitsett JA. Glucocorticoids regulate surfactant protein synthesis in a pulmonary adenocarcinoma cell line [J]. Am J Physiol.1989;257(6 Pt 1):L385-392.
[253]. Boggaram V, Smith ME, Mendelson CR. Posttranscriptional regulation of surfactant protein-A messenger RNA in human fetal lung in vitro by glucocorticoids [J]. Mol Endocrinol.1991;5(3):414-423.
[254]. Nichols KV, Floros J, Dynia DW, Veletza SV, Wilson CM, Gross I. Regulation of surfactant protein A mRNA by hormones and butyrate in cultured fetal rat lung [J]. Am J Physiol.1990;259(6 Pt 1):L488-495.
[255]. Schellhase DE, Shannon JM. Effects of maternal dexamethasone on expression of SP-A, SP-B, and SP-C in the fetal rat lung [J]. Am J Respir Cell Mol Biol.1991;4(4):304-312.
[256]. Phelps DS, Floros J. Dexamethasone in vivo raises surfactant protein B mRNA in alveolar and bronchiolar epithelium [J]. Am J Physiol.1991;260(2 Pt1):L146-152.
[257]. Connelly IH, Hammond GL, Harding PG, Possmayer F. Levels of surfactant-associated protein messenger ribonucleic acids in rabbit lung during perinatal development and after hormonal treatment [J]. Endocrinology. 1991;129(5):2583-2591.
[258]. Boggaram V, Smith ME, Mendelson CR. Regulation of expression of the gene encoding the major surfactant protein (SP-A) in human fetal lung in vitro. Disparate effects of glucocorticoids on transcription and on mRNA stability [J]. J Biol Chem.1989;264(19):11421-11427.
[259]. George TN, Miakotina OL, Goss KL, Snyder JM. Mechanism of all trans-retinoic acid and glucocorticoid regulation of surfactant protein mRNA [J]. Am J Physiol.1998;274(4Pt 1):L560-566.
[260]. Alcorn JL, Gao E, Chen Q, Smith ME, Gerard RD, Mendelson CR. Genomic elements involved in transcriptional regulation of the rabbit surfactant protein-A gene [J]. Mol Endocrinol.1993;7(8):1072-1085.
[261]. Smith CI, Rosenberg E, Reisher SR, Li F, Kefalides P, Fisher AB, Feinstein SI. Sequence of rat surfactant protein A gene and functional mapping of its upstream region [J]. Am J Physiol.1995;269(5 Pt 1):L603-612.
[262]. Kouretas D, Karinch AM, Rishi A, Melchers K, Floros J. Conservation analysis of rat and human SP-A gene identifies 5'flanking sequences of rat SP-A that bind rat lung nuclear proteins [J]. Exp Lung Res. 1993;19(4):485-503.
[263]. Young SL, Fram EK, Spain CL, Larson EW. Development of type II pneumocytes in rat lung [J].Am J Physiol.1991;260(2 Pt 1):L113-122.
[264]. Shimizu H, Miyamura K, Kuroki Y. Appearance of surfactant proteins, SP-A and SP-B, in developing rat lung and the effects of in vivo dexamethasone treatment [J]. Biochim Biophys Acta.1991; 1081 (1):53-60.
[265]. Liley HG, White RT, Warr RG, Benson BJ, Hawgood S, Ballard PL. Regulation of messenger RNAs for the hydrophobic surfactant proteins in human lung [J]. J Clin Invest.1989;83(4):1191-1197.
[266]. Weaver TE, Sarin VK, Sawtell N, Hull WM, Whitsett JA. Identification of surfactant proteolipid SP-B in human surfactant and fetal lung [J]. J Appl Physiol.1988;65(2):982-987.
[267]. O'Reilly MA, Gazdar AF, Morris RE, Whitsett JA. Differential effects of glucocorticoid on expression of surfactant proteins in a human lung adenocarcinoma cell line [J]. Biochim Biophys Acta.1988;970(2):194-204.
[268]. O'Reilly MA, Clark JC, Whitsett JA. Glucocorticoid enhances pulmonary surfactant protein B gene transcription [J]. Am J Physiol.1991;260(2 Pt 1):L37-43.
[269]. Margana RK, Boggaram V. Transcription and mRNA stability regulate developmental and hormonal expression of rabbit surfactant protein B gene [J]. Am J Physiol.1995;268(3 Pt 1):L481-490.
[270]. Pilot-Matias TJ, Kister SE, Fox JL, Kropp K, Glasser SW, Whitsett JA. Structure and organization of the gene encoding human pulmonary surfactant proteolipid SP-B [J]. DNA.1989;8(2):75-86.
[271]. Veletza SV, Nichols KV, Gross I, Lu H, Dynia DW, Floros J. Surfactant protein C:hormonal control of SP-C mRNA levels in vitro [J]. Am J Physiol. 1992;262(6Pt1):L684-687.
[272]. Glasser SW, Korfhagen TR, Bruno MD, Dey C, Whitsett JA. Structure and expression of the pulmonary surfactant protein SP-C gene in the mouse [J]. J Biol Chem.1990;265(35):21986-21991.
[273]. Glasser SW, Korfhagen TR, Wert SE, Bruno MD, Mc Williams KM, Vorbroker DK, Whitsett JA. Genetic element from human surfactant protein SP-C gene confers bronchiolar-alveolar cell specificity in transgenic mice [J]. Am J Physiol.1991;261(4Pt 1):L349-356.
[274]. Deterding RR, Shimizu H, Fisher JH, Shannon JM. Regulation of surfactant protein D expression by glucocorticoids in vitro and in vivo [J]. Am J Respir Cell Mol Biol.1994;10(1):30-37.
[275]. Ogasawara Y, Kuroki Y, Shiratori M, Shimizu H, Miyamura K, Akino T. Ontogeny of surfactant apoprotein D, SP-D, in the rat lung [J]. Biochim Biophys Acta.1991;1083(3):252-256.
[276]. Rust K, Bingle L, Mariencheck W, Persson A, Crouch EC. Characterization of the human surfactant protein D promoter:transcriptional regulation of SP-D gene expression by glucocorticoids [J]. Am J Respir Cell Mol Biol. 1996;14(2):121-130.
[277]. Cronstein BN, Kimmel SC, Levin RI, Martiniuk F, Weissmann G. A mechanism for the antiinflammatory effects of corticosteroids:the glucocorticoid receptor regulates leukocyte adhesion to endothelial cells and expression of endothelial-leukocyte adhesion molecule 1 and intercellular adhesion molecule 1 [J]. Proc Natl Acad Sci U S A.1992;89(21):9991-9995.
[278]. Kwon OJ, Jose PJ, Robbins RA, Schall TJ, Williams TJ, Barnes PJ. Glucocorticoid inhibition of RANTES expression in human lung epithelial cells [J]. Am J Respir Cell Mol Biol.1995;12(5):488-496.
[279]. Newton R, Kuitert LM, Slater DM, Adcock IM, Barnes PJ. Cytokine induction of cytosolic phospholipase A2 and cyclooxygenase-2 mRNA is suppressed by glucocorticoids in human epithelial cells [J]. Life Sci.1997;60(1):67-78.
[280]. Nakano T, Arita H. Enhanced expression of group II phospholipase A2 gene in the tissues of endotoxin shock rats and its suppression by glucocorticoid [J]. FEBS Lett.1990;273(1-2):23-26.
[281]. Mitchell JA, Belvisi MG, Akarasereenont P, Robbins RA, Kwon OJ, Croxtall J, Barnes PJ, Vane JR. Induction of cyclo-oxygenase-2 by cytokines in human pulmonary epithelial cells:regulation by dexamethasone [J]. Br J Pharmacol. 1994; 113(3):1008-1014.
[282]. Levine SJ, Benfield T, Shelhamer JH. Corticosteroids induce intracellular interleukin-1 receptor antagonist type I expression by a human airway epithelial cell line [J]. Am J Respir Cell Mol Biol.1996; 15(2):245-251.
[283]. Guy J, Dhanireddy R, Mukherjee AB. Surfactant-producing rabbit pulmonary alveolar type Ⅱ cells synthesize and secrete an antiinflammatory protein, uteroglobin [J]. Biochem Biophys Res Commun.1992;189(2):662-669.
[284]. Torkkeli T, Krusius T, Janne O. Uterine and lung uteroglobins in the rabbit. Two similar proteins with differential hormonal regulation [J]. Biochim Biophys Acta.1978;544(3):578-592.
[285]. Lombardero M, Nieto A. Glucocorticoid and developmental regulation of uteroglobin synthesis in rabbit lung [J]. Biochem J.1981;200(3):487-494.
[286]. Fogari R, Zoppi A, Lusardi P, Marasi G, Villa G, Vanasia A. Cigarette smoking and blood pressure in a worker population:a cross-sectional study [J]. J Cardiovasc Risk.1996;3(1):55-59.
[287]. Ray KP, Farrow S, Daly M, Talabot F, Searle N. Induction of the E-selectin promoter by interleukin 1 and tumour necrosis factor alpha, and inhibition by glucocorticoids [J]. Biochem J.1997;328 (Pt 2):707-715.
[288]. Robbins RA, Springall DR, Warren JB, Kwon OJ, Buttery LD, Wilson AJ, Adcock IM, Riveros-Moreno V, Moncada S, Polak J, et al. Inducible nitric oxide synthase is increased in murine lung epithelial cells by cytokine stimulation [J]. Biochem Biophys Res Commun.1994;198(3):835-843.
[289]. Kleinert H, Euchenhofer C, Ihrig-Biedert I, Forstermann U. Glucocorticoids inhibit the induction of nitric oxide synthase Ⅱ by down-regulating cytokine-induced activity of transcription factor nuclear factor-kappa B [J]. Mol Pharmacol.1996;49(1):15-21.
[290]. Di Rosa M, Radornski M, Carnuccio R, Moncada S. Glucocorticoids inhibit the induction of nitric oxide synthase in macrophages [J]. Biochem Biophys Res Commun.1990;172(3):1246-1252.
[291]. Knowles RG, Salter M, Brooks SL, Moncada S. Anti-inflammatory glucocorticoids inhibit the induction by endotoxin of nitric oxide synthase in the lung, liver and aorta of the rat [J]. Biochem Biophys Res Commun. 1990; 172(3):1042-1048.
[292]. Radomski MW, Palmer RM, Moncada S. Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells [J]. Proc Natl Acad Sci U S A. 1990;87(24):10043-10047.
[293]. Matsuba T, Keicho N, Higashimoto Y, Granleese S, Hogg JC, Hayashi S, Bondy GP. Identification of glucocorticoid-and adenovirus E1A-regulated genes in lung epithelial cells by differential display [J]. Am J Respir Cell Mol Biol.1998;18(2):243-254.
[294]. Friedland J, Setton C, Silverstein E. Angiotensin converting enzyme:induction by steroids in rabbit alveolar macrophages in culture [J]. Science. 1977;197(4298):64-65.
[295]. Mendelsohn FA, Lloyd CJ, Kachel C, Funder JW. Induction by glucocorticoids of angiotensin converting enzyme production from bovine endothelial cells in culture and rat lung in vivo [J]. J Clin Invest. 1982;70(3):684-692.
[296]. Chen ZJ, Parent L, Maniatis T. Site-specific phosphorylation of IkappaBalpha by a novel ubiquitination-dependent protein kinase activity [J]. Cell. 1996;84(6):853-862.
[297]. Liggins GC, Howie RN. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants [J]. Pediatrics.1972;50(4):515-525.
[298]. Banks BA, Cnaan A, Morgan MA, Parer JT, Merrill JD, Ballard PL, Ballard RA. Multiple courses of antenatal corticosteroids and outcome of premature neonates. North American Thyrotropin-Releasing Hormone Study Group [J]. Am J Obstet Gynecol.1999;181(3):709-717.
[299]. Kari MA, Akino T, Hallman M. Prenatal dexamethasone and exogenous surfactant therapy:surface activity and surfactant components in airway specimens [J]. Pediatr Res.1995;38(5):676-684.
[300]. Ballard PL, Ballard RA. Scientific basis and therapeutic regimens for use of antenatal glucocorticoids [J]. Am J Obstet Gynecol.1995; 173(1):254-262.
[301]. Silver RK, Vyskocil C, Solomon SL, Ragin A, Neerhof MG, Farrell EE. Randomized trial of antenatal dexamethasone in surfactant-treated infants delivered before 30 weeks' gestation [J]. Obstet Gynecol.1996;87(5 Pt 1):683-691.
[302]. Harding JE, Pang J, Knight DB, Liggins GC. Do antenatal corticosteroids help in the setting of preterm rupture of membranes? [J]. Am J Obstet Gynecol. 2001; 184(2):131-139.
[303]. Murphy BE. Conjugated glucocorticoids in amniotic fluid and fetal lung maturation [J]. J Clin Endocrinol Metab.1978;47(1):212-215.
[304]. Beers MF, Shuman H, Liley HG, Floros J, Gonzales LW, Yue N, Ballard PL. Surfactant protein B in human fetal lung:developmental and glucocorticoid regulation [J]. Pediatr Res.1995;38(5):668-675.
[305]. Rebello CM, Ikegami M, Polk DH, Jobe AH. Postnatal lung responses and surfactant function after fetal or maternal corticosteroid treatment [J]. J Appl Physiol.1996;80(5):1674-1680.
[306]. Ikegami M, Polk DH, Jobe AH, Newnham J, Sly P, Kohan R, Kelly R. Effect of interval from fetal corticosteriod treatment to delivery on postnatal lung function of preterm lambs [J]. J Appl Physiol.1996;80(2):591-597.
[307]. Jobe AH, Ikegami M. Antenatal infection/inflammation and postnatal lung maturation and injury [J]. Respir Res.2001;2(1):27-32.
[308]. Jobe AH. Glucocorticoids, inflammation and the perinatal lung [J]. Semin Neonatol.2001;6(4):331-342.
[309]. van der Heide-Jalving M, Kamphuis PJ, van der Laan MJ, Bakker JM, Wiegant VM, Heijnen CJ, Veen S, van Bel F. Short-and long-term effects of neonatal glucocorticoid therapy:is hydrocortisone an alternative to dexamethasone? [J]. Acta Paediatr.2003;92(7):827-835.
[310]. Andre P, Thebaud B, Odievre MH, Razafimahefa H, Zupan V, Dehan M, Lacaze-Masmonteil T. Methylprednisolone, an alternative to dexamethasone in very premature infants at risk of chronic lung disease [J]. Intensive Care Med.2000;26(10):1496-1500.